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 Abstract 
Mussel adhesive proteins contain catechol moiety, which allows the protein to 
crosslinked, solidify, and adhere to surrounding surfaces even under wet conditions. 
Incorporating the catechol moiety into polymeric adhesive resulted in bioadhesive, which 
still functions under wet conditions. However, the adhesive must be oxidized in order to 
crosslink and adhere to surfaces. The oxidation process of catechol adhesive was proven 
to produce singlet oxygen, superoxide, and hydrogen peroxide (H2O2). These reactive 
oxygen species, with lack of control, can wreak havoc to the biological system causing 
poor healing and undesired biological response.  
Here, we studied the silica particle system as a means to control H2O2 concentration. 
After an exploratory investigation on silica particle synthesis and modification, acid-
treated silica particle (AHSi) was developed with a highly hydrophilic surface. We then 
explore the use of reinforcement phase incorporation, creating particle-adhesive 
composites and studied the effect which the particle incorporation imparts into the 
adhesives. The model adhesive is polyethylene glycol functionalized with glutaric acid 
and dopamine, creating a biodegradable adhesive hydrogel. We demonstrated that 
incorporation of a model particle, silica particle, into a catechol adhesive resulting in a 
mechanically stronger adhesive with an increase in stiffness, adhesion strength, and 
structural integrity even after partially degraded. Moreover, the composite adhesive was 
gelled faster and degrade slower than native PEG-DA adhesive. The composite also 
xxii 
demonstrated a reduction in the concentration of H2O2. The particle not only reduces 
H2O2 but also found to be releasing soluble silica in a biologically relevant concentration 
further improve their bioreactivity. The silica nanoparticle incorporated catechol-based 
composite demonstrated a reduction in cytotoxicity on rat dermal fibroblast, human 
keratinocyte, and human tenocyte, three types of cells that react differently to elevated 
oxidative stress. 
Interestingly, all cell types have demonstrated an increase in cell proliferation, raising the 
possibility of developing the composite adhesive further. The last part of the study 
involved a prediction model that helps narrow down the formulation to be tested in vivo. 
Full-thickness dermal wound model in mice was utilized to study the predicted 
formulation. The results from the animal model suggested that PEG adhesive alone can 
alter the biological response with accelerated wound healing. However, the incorporation 
of AHSi proved to successfully bridge the gap between accelerated wound healing and 
better wound remodeling. This dissertation describes various strategies used to tune the 
H2O2 concentration released from catechol adhesives to tune its biological response 
which involved silica particle modification with minimal change in chemical 
composition, and the selection of adhesive formulation to enhance the wound healing and 
wound remodeling.   
 
  
1 
1 Multifunctional Catechol Adhesive Composite Design1 
1.1 Introduction 
Wound closure, surgical repair, and reconstruction of traumatized or degenerated soft 
tissues frequently occur in medicine. These procedures involve rejoining biological tissue 
surfaces or securing implantable devices (e.g., surgical meshes, grafts, etc.) to living 
tissues 1-3. Conventionally, the use of sutures and staples have been the primary means to 
achieve such wound closure or implant fixation 4-6. However, these methods lead to 
additional trauma, leakage, and a lack of tissue integration resulting from significant 
compliance mismatch between the tissue and the fixation device 7-10. Biomedical 
adhesives can potentially overcome these limitations and provide additional benefits such 
as reducing surgical time, minimizing treatment invasiveness, reducing additional trauma, 
and preventing body fluid leakage 1-3, 11, 12.  
Despite the potential benefits of tissue adhesives, commercially available bioadhesives 
have limited applications due to limited functionality. Specifically, existing adhesives are 
primarily designed to have one key function, which is to provide mechanical support for 
the repaired tissue. To expand the potential utilization of bioadhesive in medicine, 
researchers have reported novel multifunctional bioadhesives with improved 
performance. Multifunctional bioadhesives not only need to meet the requirement of 
 
1 Parts of the material contain in this chapter was previously published in Advanced healthcare 
materials, 8(11), p.1801568. https://onlinelibrary.wiley.com/doi/full/10.1002/adhm.201801568 
2 
adhering to biological tissues but also have added functions aimed at improving the 
outcome of the wound healing process. Biomedical adhesives can be engineered to have 
an antimicrobial property to minimize microbial growth and prevent acute complications. 
Some bioadhesives are also designed to self-heal when damaged, which will prolong the 
service life of the adhesive. Stimuli-responsive bioadhesives are designed to respond to 
externally applied triggers such as pH, electricity, temperature, light, or changes in the 
wound environment to promote cellular migration, tissue-specific gene expression, and 
native tissue healing. The ability to respond to externally applied stimuli enables these 
adhesive to release therapeutic drugs or change their adhesive property on command in 
response to dynamic physiological conditions. 
Recent advances in mono-functional bioadhesives have been reviewed elsewhere 1-3, 13, 14, 
and will not be the focus of this review. Instead, this review paper focuses on 
multifunctional bioadhesives, which we categorize into either passive or active by design 
(Figure 1). Passive multifunctional bioadhesives contain inherent compositions and 
structural designs that can carry out additional functions (e.g., antimicrobial property, 
self-healing ability, etc.) without the need for added external factors or influences. 
Conversely, active multifunctional bioadhesives respond to environmental changes (e.g., 
pH, electricity, temperature, light, biomolecule concentration, etc.), which triggers a 
chemical or structural change within the adhesive that initiate the added function of the 
adhesive. These environmental triggers could be applied externally by the user after the 
adhesive has been deployed or internally triggered resulting from the natural 
physiological responses to the presence of the adhesive (e.g., normal wound healing 
3 
response) or physiological conditions of the biological environment (e.g., elevated insulin 
concentration in a diabetic patient).  In this review, we address fundamental criteria for 
designing a bioadhesive, review the existing bioadhesives in the market, and review 
passive and active multifunctional bioadhesives reported in the literature.  
 
Figure 1. Multifunctional biomedical adhesive design considerations. The 
fundamental attributes of any successful biomedical adhesive include an application-
specific balance of appropriate cohesive and adhesive interactions coupled with the 
biocompatibility of the bulk adhesive material as well as any products generated during 
the curing process or degradation of the adhesive with time. Passive and active design 
elements can be used to ultimately tailor or refine these core attributes in multi-functional 
bioadhesives to more specifically target an overall desired outcome.  
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1.2 Key criteria for biomedical adhesive design 
Regardless of the type, function, or the intended application of a bioadhesive, there are 
three key criteria that all bioadhesives should satisfy 1-3, 11-14. These criteria include the 
ability to form strong interfacial bonds, the ability to retain strong bulk cohesive 
properties after curing, and the necessity to remain biocompatible throughout the lifetime 
of the bioadhesive. This section reviews these key design criteria for bioadhesives.  
1.2.1 Interfacial interactions 
Biomedical adhesives need to form strong interfacial bonds with tissue substrates 11, 12. 
For fixation of surgical implants, bioadhesive may need to adhere strongly to surfaces 
with different surface properties and chemical makeup (i.e., metal, polymer, ceramic). 
These interfacial bonds can include chemical crosslinking, physisorption, diffusion, 
electrostatic interaction, physical interlocking, and micromechanical interactions. Most 
bioadhesives utilize more than one type of interaction to bond to these surfaces. Chemical 
crosslinking consists of strong interfacial covalent bonds (Figure 2). Commonly used 
interfacial chemistries involve activated ester (e.g., N-hydroxysuccinimide (NHS) 
activated acid group), isocyanate, and aldehyde functional groups, which are reactive 
toward primary amine found on the surface of soft tissues (e.g., -NH2 of lysine) 
13. 
Catechol mimics the reactivity of the adhesive amino acid, 3,4-dihydroxyphenylalanine 
(DOPA), found in mussel adhesive proteins 15, 16. The catechol-modified adhesive is 
capable of binding to both tissue and inorganic substrates (i.e., polymer, metal). 
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Additionally, catechol-dimerization has also been shown to enhance wet adhesion 
toughness 17. Physisorption involves weak intermolecular forces such as van der Waals 
interaction resulting from positively and negatively charged regions within bonding 
molecules 18. Physisorption is known to perform poorly within a moisture-rich 
environment as water interferes with the weak molecular interaction 19. As such, a 
bioadhesive that relies solely on van der Waals interaction may not be effective in a 
biological system. Diffusion of polymer networks across interfaces occurs when the 
adherent and substrate surfaces are mutually soluble, and their polymer chains have 
sufficient mobility 18. Polymer diffusion is favorable in highly hydrated conditions and 
may be limited to bioadhesives designed for moisture-rich environments, such as blood 
vessel or digestive tracks. Ionic adhesives with positive or negative charges can bind to 
surfaces with the opposite charge through electrostatic interactions 20. Electrostatic 
interaction can be modulated by changing the ionic environment surrounding the 
adhesive, which may be useful in designing smart adhesives that respond to changes in 
pH.  
Depending on the desired application, there may be different performance criteria that the 
bioadhesive needs to satisfy.  For example, Pascual et al. 21 reported that abdominal wall 
repair using a surgical mesh required a fixation strength of 55-60 N, and cyanoacrylate-
based adhesive was equally as successful as suture fixation. Sutures have high tensile 
strength (8 to 15 N)22 and require minimal footprints for repair. However, the 
performance of bioadhesives is highly dependent on the overlapped surface area between 
the adhesive and the substrates. To perform microneural anastomosis, Choi et al. 23 
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overlapped the epineuriums of the two nerve ends and then applied cyanoacrylate-based 
adhesive. This method was comparable to sutured anastomosis. To function as a lung 
sealant, a burst pressure of 30-60 mmHg may be sufficient 3, 24. However, a significantly 
higher burst pressure (200-400 mmHg) may be required for sealing renal veins 25 or 
sutured intestinal anastomosis 26. Hence, to design an effective adhesive, it is necessary to 
understand the parameters specific to the surgical procedures.  
 
Figure 2. Interfacial crosslinking chemistries between adhesive functionalized using 
NHS-activated ester (A), isocyanate (B), aldehyde (C), and catechol (D) with 
nucleophilic functional groups (e.g., -NH2 of lysine) found on soft tissues. Catechol can 
also form coordination bonds with metal oxide surfaces, which may be present on the 
surface of an implant or medical device (E). 
 
A B C 
D E 
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1.2.2 Curing of adhesive and cohesive properties 
In addition to forming strong interfacial bonds, a bioadhesive must also develop cohesive 
strength after it has been applied. The adhesive must remain stable for the duration of its 
service life to provide adequate support for a wound to heal. For an injectable 
bioadhesive, the adhesive must be able to transform from the liquid state into the solid-
state under mild physiological conditions. This physical change should be rapid (typically 
3 to 5 minutes) to minimize surgical procedure time 1. The curing process typically 
involves the formation of intermolecular crosslinking, which can be achieved via the 
mixing of reactive components or activated by external stimuli such as ultraviolet (UV) 
light 27. However, the use of longwave UV (e.g., UVA) is preferred over medium-wave 
UV (UVB) to minimize tissue damage 28. After curing, the bioadhesive must possess the 
bulk mechanical strength necessary to withstand mechanical forces applied by the 
surrounding tissues. A tissue adhesive with adhesive strength and biomechanical 
properties matching those of native tissues can potentially be used to repair tissues that 
routinely experience repeated loads (e.g., cartilage, tendon, and ligament). Ideally, a 
bioadhesive must be designed to match the material properties of the target tissue (e.g., 
elastic modulus of 102-104 Pa for soft connective tissue and >104 Pa for muscle, cartilage, 
and bone)29.  A tightly secured tissue repair will allow patients to undergo early, 
aggressive rehabilitation programs to promote regeneration of functional tissue, which is 
especially critical for relatively avascular tissues that are known to heal poorly otherwise. 
Bioadhesives with enhanced bulk mechanical properties also exhibit better adhesion 
performance 30. Additionally, it is important to control the swelling behavior of the cured 
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adhesive. Hydrophilic bioadhesives can potentially swell excessively, which is 
undesirable as it can lead to severe medical complications such as local nerve 
compression 31, 32. Increased water content can also compromise the mechanical 
properties of the adhesive due to decreased crosslinking density  33. 
1.2.3 Biocompatibility and biodegradability of biomedical adhesives 
One of the key criteria for a bioadhesive is that it needs to remain biocompatible during 
deployment as well as during its service life 34. The typical curing process of an adhesive 
involves chemical crosslinking, and it is important that the release of reactive chemicals 
into the surrounding tissue is minimized. The introduction of the bioadhesive into the 
body is expected to generate an acute inflammatory response. However, it is not desirable 
for the bioadhesive to illicit sustained chronic responses 35. In addition, unlike sutures or 
staples, adhesives can act as a barrier to the union of tissue surfaces. The ability of the 
bioadhesive to degrade with time as the tissue heals is important. However, the adhesive 
needs to maintain its mechanical integrity for a period of time immediately after surgery 
to prevent premature rupture of the repaired tissue. Degradation byproducts must be non-
cytotoxic and, ideally, an adhesive should support rapid native cellular ingrowth and gene 
expression to regenerate functional tissue.  
1.3 ROS production from Catechol adhesive 
Catechol (1,2-dihydroxy benzene) is an organic compound that is commonly found in the 
DOPA molecule, which is secreted by mussel along with mussel adhesive proteins. In a 
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synthesis polymer preparation, dopamine moiety is commonly used to impart the catechol 
functionality onto various polymer backbones (i.e., polyacrylamide, PEG), resulting in 
the synthetic adhesive, which can perform under wet condition. However, the process 
gelation and crosslinking of such adhesive required periodate chemistry or other types of 
oxidants to facilitate the oxidation process of the catechol moiety (Figure 3). Catechol 
oxidized into quinone in the presence of O2 resulted in superoxide formation leading to 
more oxidization of catechol through superoxide mediated oxidation. The superoxide 
mediated oxidation then oxidizes catechol to quinone but no longer generate superoxide 
but hydrogen peroxide instead. Since superoxide can also interact directly with protons, 
  
Figure 3. NaIO4-mediated catechol oxidation to quinone and crosslinking. ROS, such as 
superoxide (O2˙
‒) and hydrogen peroxide (H2O2), are generated during the process. R = 
PEG polymer 
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more H2O2 and O2 can be generated as a result. This chemical reaction loop will continue 
until no catechol is left to be oxidized. Since H2O2 half-life is significantly longer (hours 
vs. seconds) than those of superoxide, H2O2 is the main species of interest to control in 
order to tailor the biological response from catechol based adhesive36.  
1.4 H2O2 and its biological functions 
H2O2 is a chemical substance that promptly used within living cells. It is known to govern 
many critical biological functions through the participation in oxidative biosynthesis 
functions in cells. Additionally, there is evidence pointing that cells exhibit a 
concentration-dependent response to H2O2 (Table 1.). At low concentration, it plays a 
crucial role as a signaling agent between cells. At an elevated concentration, it was 
observed to be serving as a defense mechanism for foreign invaders or kick start the 
inflammatory response. At a high concentration, H2O2 can break down biological tissues 
and denature proteins. H2O2 was utilized in biomedicine since the 1800s as biocidal agent 
37. Recently, H2O2 (100 µM) was utilized not for their biocidal purposes but for wound 
lysate, induced angiogenesis, and allows new tissue growth 38. However, actively remove 
H2O2 by catalase enzyme delayed wound healing as eschar formation is disrupted. On the 
other hand, a higher dose of H2O2 (≥ 105 µM) retarded the wound healing and form a 
chronic wound as oxidative damage was done. However, at this concentration, H2O2 can 
achieve bacteriostatic 39. H2O2 concentration should be at least 106 µM in order to 
function as a bactericide agent 40. Sustaining release of H2O2 (10-10
3 µM) from ascorbate 
acid selectively kill cancer cells but leave normal cells live41. More recently, a large dose 
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of 1 M was shown to completely kill both gram-positive and gram-negative bacterial as 
well as to deactivate both enveloped and non-enveloped virus42. Thus, the H2O2 
concentration can be modulated to show different functions matched different 
applications and desired biological responses. 
 
Table 1. H2O2 concentration and their correlated biological effect 
[H2O2] (µM) Biological Effect 
Actively remove Delayed dermal wound healing 
102 Delayed tenocyte proliferation 
102-103 Accelerate dermal wound healing 
103 Bacteriostatic (E. coli) 
105 Delayed dermal wound healing 
106 Biocide and virucide 
Sustain release of 101-103 Kill cancer cells but safe for healthy cells 
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1.5 H2O2 degradation and control method.  
H2O2 degradation was done naturally within a living organism through the use of catalase 
enzyme. The enzyme is highly efficient and can break down H2O2 into H2O and O2
43. 
Catalytic degradation of H2O2 can also be achieved with a metal catalyst. Platinum, 
palladium, and iron are among the examples of metal groups that can catalytically 
breakdown H2O2
44, 45. However, metalloid oxides, SiO2, was also found to be able to 
break down H2O2 in a similar manner to those of the metal oxides
44. The degradation rate 
of H2O2 with SiO2 was reportedly slower by at least an order of magnitude (when 
compare to AIO3) to up to 3 order of magnitude ( when compare to ZrO2) when 
compared to other conventional metal and ceramics44. Decomposition is not the only 
mean of control for silica over H2O2, however. Multimember complexation between 
H2O2, SiOH, and H2O was reported as a stable complexation which allows for a 
reduction in measurable H2O2
46, 47. The absorption was reported as reversible, which 
would allow the adsorbed H2O2 to participate in catalytic decomposition as the molecule 
of H2O2 are in close proximity of the silica-based material surface. 
1.6 Silica particle as reinforcement and bioactive additives 
The incorporation of inorganic nanoparticles (NP) into polymeric matrices provides a 
simple approach to create nanocomposites with improved mechanical properties and 
tailored biological responses 48, 49. This reinforcement strategy of using NP to form 
physical and chemical crosslinks within a polymer network has been rigorously studied in 
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the past decades. Specifically, nanoparticles used in biomedical applications include 
silica (Si) particle, bioactive glass, and hydroxyapatite 48, 50-52. Among these particles, Si 
particles are one of the most commonly used, with key examples such as magneto-
luminescence composites 53, drug-releasing composite 54, and composites with elevated 
mechanical property 49, 55. Additionally, Si NP degrades into silicic acid, which has been 
found to be beneficial for bone and connective tissue formation and remodeling 56, 57. 
Despite the advantages associated with Si NP, some reported the toxicity of these 
particles due to its reduced size 56, 58, 59. The cytotoxicity of NP is associated with the 
direct physical interaction between the particle and cell membrane, resulting in the 
cellular internalization of NP 60. Particles with a larger size exhibited reduced 
cytotoxicity, as the internalization process is hindered when the particle size approaches 
micron scale 56, 58, 59, 61. However, the performance of the micron-sized particle is inferior 
to that of NP in improving the mechanical properties of polymer matrices, due to a 
significant reduction in the surface area as well as the limitation in particle dispersion 62, 
63. To overcome the cytotoxicity associated with NP and the reduced performance of 
micron-sized particles as a filler, we prepared clustered microparticles (MP) that were 
formed through the clustering of NP. We hypothesized that the clustered MP would have 
reduced cytotoxicity due to its increased size while retaining nano-scaled surface features 
with an enhanced surface area for interacting with the polymer matrix (Scheme 1). 
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Scheme 1. Schematic representation of the chemical interactions involved in the curing 
and adhesion processes of the composite adhesive. PEG-DA contains catechol end-
groups that can interact with silica nano- and microparticles (NP and MP, respectively) 
through strong reversible interactions (A). Oxidation of catechol in the presence of 
NaIO4 forms highly reactive quinone, which results in catechol polymerization and curing 
of the adhesive (B), as well as the formation of an interfacial covalent bond with 
nucleophilic function groups (i.e., –NH2 of lysine) and adhesion to the surface of soft 
tissue (C). Reproduced from reference 64 with permission from IOP Publishing copyright 
2020. 
1.7 Statement of purpose and experiment set-up  
Mussel inspired catechol-based adhesive has gained popularity in research in recent 
years. However, only recently that our group has identified the byproduct to be singlet 
oxygen, superoxide, and H2O2. It is crucial to understand their biological responses and 
able to has reasonable control over such a byproduct. H2O2 are the most stable reactive 
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oxygen species among all aforementioned all byproduct, and its biological effect is well 
understood. The concentration-dependent biological response of the H2O2 allows the 
unique approach in material design to take shape. Depending on the concentration and the 
exposure time, H2O2 can cause a variety of cellular and tissue responses ranging from 
accelerated wound healing (tissue-specific, ranging from 10-103µM) to tissue 
denaturation (>104µM). Therefore, H2O2 concentration can be modulated to fit different 
types of tissues and applications. One way of controlling hydrogen peroxide is through 
the use of silica particles. We first investigate and master our capability in controlling the 
particle synthesis before chemically altering the surface chemistry of the particle. Then 
the particle was subjected to complexation tests with H2O2 to determine their efficiency 
and affinity toward H2O2 control.  We then study the use of silica particles as a modulator 
for H2O2 byproduct in the form of composite additives. The composite then subject to 
physical (i.e., gelation, rheometry, lap shear), chemical (i.e., Fourier Transform Infrared 
Spectroscopy, stability test), and biological (i.e., in vitro cell response) tests to determine 
and confirm the expected changes with the focus on the biological response. H2O2-Silica 
particle complexation was found to be a viable option not only for the reduction of H2O2 
but also for the unique property of highly hydrophilic silica particles, which allows the 
release of soluble silica out of the composite adhesive. The first approach for silica 
nanoparticle incorporated catechol-based bioadhesive was studied as a feasibility material 
model. The composite adhesive was utilized to evaluate the extent of control over H2O2 
concentration and cellular responses. The study is also used to confirm that the addition 
of silica particles will not hinder the main function of the adhesive, which are remaining a 
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strong adhesive. Polyethylene glycol is selected as the backbone material because it has 
been approved by the FDA and was used in many applications, including cell 
encapsulation 65, scaffolding66, and drug delivery67. Silica was thought to be bioinert or 
cytotoxic. However, recent understanding shines a new light on the material. Crystallinity 
59, size 58, and surface charge68 of the particle govern their reactivity with living cells. 
Combing with PEG hydrogel, they are ideal biocompatible composite systems that the 
biological responses to the hydrogel can be fully contributed to the H2O2 released during 
catechol autoxidation and the resulting modulation of H2O2 from the particle. It is clear 
from the previous study that adding particle alone has limited use when specific 
applications required a higher concentration of H2O2 (i.e., antimicrobial, dermal wound 
healing). As a result, the continuation study was utilizing the robust design of experiment 
approach to predict and narrow down the formulation to be tested for, specifically, 
dermal wound healing application. Full thickness wound model in mice was selected as 
the model to study the effect of adhesive architecture, H2O2 concentration, and particle 
incorporation on the wound healing process. With more flexible formulation selection, 
silica particle role was changed from scavenger in the previous study into a complete 
modulator allowing for the fine tuning of H2O2 to be achieved. Finally, the wound 
healing response to the treatment of the adhesive and their composites were determined. 
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2 Synthesis, Modification, and Characterization of Silica 
Particle and Catechol-Based Polyethylene Glycol Adhesive2 
2.1 Synthesis, Modification, and Characterization of Silica Particle 
2.1.1 Understanding Silica Particle and Their Biological Effect  
Two of the most commonly used silica precursors in both industry and research include 
tetraethyl orthosilicate (TEOS), tetramethyl orthosilicate (TMOS), and sodium silicate 
(Na2SiO3) or water glass 
69-71. All silica precursors produce the final product through the 
process of hydrolysis and condensation of silicic acid precursors under catalysts resulting 
in predominantly silicon dioxide product 72. Both acidic and basic conditions can be used 
to catalyze the reaction as protonation of alkoxide can occur faster with the extra protons 
from the acid species during the hydrolysis process (Figure 4) 70, 72. However, the extra 
protons in from the acid species also allow the interaction between silanol groups and 
ethoxy groups to occur, slowing down the condensation process. Ultimately, the 
condensation between the silanol groups or between silanol groups and ethoxy groups 
creates siloxane bridges (Si–O–Si) that form the entire silica structure 72. The inverse 
relationship is true for the basic catalytic reaction. Hence, the acid catalyst will result in 
 
2 Parts of the content in this chapter was published in Biomedical Materials, 13(2), p.025003.Copyright 
2020 American Chemical Society. https://iopscience.iop.org/article/10.1088/1748-605X/aa985d/meta 
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fast hydrolysis and slow condensation. Inversely, the basic catalyst will result in slow 
hydrolysis and fast condensation.  
The main difference between all silica precursors is the rate of chemical conversion, 
which results in differences in the rate of silica product formation through hydrolysis and 
other preparation methods (i.e., pyrolysis, acid precipitation, etc.) (Figure 4) 72, 73. For 
instance, TMOS demonstrated to be around four times faster hydrolysis rate when 
compare to TEOS is an alkoxy preparation method 72, 73.   
TEOS and TMOS are effective silica precursors with generally higher than 90% recovery 
rate of silica product by weight when preparing through hydrolysis and more than 70% 
recover rate by weight when pyrolytically preparing through flame spray pyrolysis 
process (FSP)72, 74. FSP is the most commonly utilized method to produce silica on an 
industrial scale as there are no solvent and separation required to retrieve the final 
product 73. However, Na2SiO3 is more commonly used, and the resulting silica particle 
prepared from the FSP method has high crystallinity as high heat exposure is required for 
such synthesis method 75.  
Crystallinity is found to be one of the deciding factors in utilizing silicon-based particle 
as crystalline particle both synthetic (silica nanocrystals) and natural (i.e., mica, asbestos, 
and silicon fume) are all found to cause cell apoptosis and can leads to tissue 
degeneration especially in epithelium cells and respiratory tracts 58, 59. Additionally, 
crystallinity is also directly governing the mode of which the particle causes a biological 
response from highly toxic to cells to nearly biocompatible with higher crystallinity 
19 
resulting in higher toxicity 58, 64. It is also a deciding factor whether the particle can be 
biologically degraded through hydrolysis as the lower 
 
Figure 4. Basic-catalyzed silica hydrolysis and condensation (A) and acid-catalyzed 
silica hydrolysis and condensation. Reprint from ref. 71 and 69, with permission from  
Elsevier copyright 2020 and The Royal Society of Chemistry, respectively 
A 
B 
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crystalline particle can partially degrade through hydrolysis before being ingested by the 
cells 54, 56, 59, 76. There are studies suggested that the degraded product of the amorphous 
silica particle is silicic acid, which can contribute to increased cell proliferation and cell 
migration 56, 76. As a result, most research in biomedicine, when utilized silica-based 
materials, are willingly lowering crystallinity with a compromise on the use of solvent 
and separation technique to ensure an improved biological response.     
2.1.2 Stӧber Synthesis Method 
In 1968, Werner Stöber and his research team had reported a new approach in 
synthesizing particulate in an aqueous reactor with ammonia as a catalyst to control the 
hydrolysis and condensation kinetics of ethoxy silane in alcohol 70, 77. The resulting 
product is a fine powder of uniform silica particles (Scheme 2). For Stӧber synthesis, 
morphological and size distribution controlled are the main benefit of getting from the 
synthesis method. The key synthesis methods derived from Stӧber finding may include 
Bogush and Zukoski 74. The investigation of factors that affect the particle formation in 
this synthesis method may include a selection of silica precursors, the use of surfactant, 
application of shear force, pH, and temperature of the reactor solution70, 72, 78, 79. These 
factors are not only affecting the final product, the particle but also affect the reaction 
speed, separation method, purification method, etc. The modified Stöber method utilized 
the understanding of these factors and modified the synthesis setup, so the researcher has 
more control than the initial concept proposed by Stӧber and his colleagues. 
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Scheme 2. representation of simplified Stöber synthesis. Reproduce from Ref. 70 with 
permission from Elsevier copyright 2020 
2.1.3 Exploratory Experiment on Modified Stӧber Synthesis Method 
2.1.3.1 Material  
Tetraethyl orthosilicate (TEOS, 99.8%), methanol, ethanol (200 proof), potassium 
hydroxide (pallet, 85%), sodium hydroxide (NaOH, 50% w/w), cetrimonium bromide 
(CTAB, 99.9%), acetic acid (CH3COOH, glacial 98%), and hydrochloric acid (HCl, 
37%) were purchased from Fisher Scientific (Pittsburgh, PA). 
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2.1.3.1 Method  
The synthesis setup consisted of a hot plate stirrer with digital temperature and speed 
indicator (Fisher Scientific), Erlenmeyer flask with appropriate volume (100-500 ml), a 
glass flask adapter (24/40), and rubber caps. A glass reflux column setup was utilized 
during the purification and surface modification to contain escaping acidic fume 
(Figure5). Aluminum foil was used to create a localized heat radiator to improve 
temperature management. For the basic catalyst experiment, 12.5 ml of NaOH was added 
to 250 ml of ethanol/deionized water mixed solution (1:1 v/v) under vigorous stir to 
create a basic reactor solution. For the acid catalyst experiment, 20 ml of HCl was added 
to 250 ml of ethanol/deionized water mixed solution (1:1 v/v) under vigorous stir to 
create an acid reactor solution. 9.7 ml of TMOS and 10.6 ml of TEOS (1g) was added to 
the reactor solutions dropwise. The mixed solution was allowed to react for 1 or 12 hours 
before the solution was collected and filtered through a paper filter with a pore size of 40 
µm to remove large contaminants and aggregates. The filtered solution was then 
transferred to a centrifuge tube. Ultracentrifugation (10000 Gs) was utilized to collect the 
particle. The filtered solution was centrifuged for 15 minutes; then the supernatant was 
discarded. The particle was then resuspended in 40 ml deionized water to remove residual 
acid or base. The purification was repeated three times. The resulting particle was then 
dried under vacuum for 48 hours before weighting to fund the recovery rate. The 
recovery rate was calculated via the following equation: 
    %R = 100×W1÷0.461     (1) 
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Where %R is the recovery rate of the particle, and W1 is the weight of the dried particle. 
0.461 was derived from the precursor silica conversion as 1 g of silica precursor would 
result in 0.461 g of SiO2 with 100% conversion efficiency     
 
Figure 5. Equipment setup for silica particle surface modification. Yellow box indicates 
the flask convertor and reflux column connection 
 
Table 2. Exploratory silica particle synthesis condition 
Silica 
Precursor 
Condition Time (hours) Approx. Recovery 
(%) 
TMOS pH 1 25oC 400 rpm 1 30 
24 
12 66 
pH 11 25oC 400 rpm 
1 75 
12 84 
TEOS 
pH 1 25oC 400 rpm 
1 12 
12 65 
pH 11 25oC 400 rpm 
1 64 
12 77 
The results indicated that TMOS is a more efficient silica precursor as it can form silica 
particles more rapidly when compared to TEOS (Table 2). However, TMOS produced a 
higher amount of aggregates as well as was found to generally be harder to control 
morphology and size 80, 81. As a result, TEOS was selected to be the main silica precursor 
in this study. 
As a continuation in particle synthesis, nonporous silica nanoparticle (NSi) was prepared 
using a modified Stöber method without surfactant 64. The silica precursor solution was 
prepared by mixing 4 g of TOES with 50 mL of ethanol and sonicated for 10 minutes. 
The reactor solution was prepared with 25 mL deionized water mixed with 30 mL ethanol 
and vigorously stirred (15 minutes at 400rpm) using a hot plate stirrer at 75oC.  The pH of 
the reactor solution was maintained at pH 11 by adding 0.1 M NaOH. The silica 
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precursor solution was added dropwise into the reactor solution at a rate of approximately 
300 µl/second while stirring at 400 rpm. The solution turned milky white immediately 
after the precursor have been added to the reactor solution. After stirring for 1 hour at 75 
oC, the pH of the reaction mixture was neutralized by adding 0.1 M acetic acid. The 
reaction mixture was further stirred for an additional 12 hr at room temperature. The 
reaction mixture was filtered using a filter paper with a mesh size of 20 µm to remove 
large contaminants. Ultra-highspeed centrifugation (10000 Gs) was used to separate the 
particles from the solution. The particles were washed vigorously three times with 
ethanol to ensure complete dehydration and removal of sodium acetate. After drying 
under a vacuum of 24 hrs, the yield of NP was 1.5 g. Mesoporous silica particles with 
low (LSi) and high (HSi) porosity were prepared using the same Stöber method with 
CTAB as a surfactant. The silica precursor solution was prepared by mixing 0, 9.4, or 
18.8 g of CTAB (for NSi, LSi, and HSi, respectively) into 500 ml of ethanol and water 
mixed solution (2:1 v/v ratio) and vigorously stirred (15 min at 400 rpm) at 55 °C via a 
heating manifold and pH 11 by adding 0.1M NaOH dropwise. Then, 10 ml of TEOS 
solution was added dropwise into the reaction solution at a rate of approximately 300 μl 
s−1 while stirring at 1000 rpm. The mixed solution was left stirring for 1 hour at 55 °C 
and pH 11, then the heating manifold was removed, and the pH of the reaction mixture 
was neutralized by adding 0.1M HCl dropwise. The mixture was further stirred for an 
additional 15 minutes at room temperature. The reaction mixture was centrifuged at 
10,000 kGs then washed three times with methanol, ethanol, and deionized (DI) water. 
The particles were dried under vacuum for 24 hours and sifted using American Society 
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for Testing and Materials (ASTM) 450 (32 μm) sifters to remove any large contaminants 
and aggregates. The yield of the NSi, LSi, and HSi particles was 75%, 68%, and 66%, 
respectively. 
2.1.4 Surface modification 
Silica and silicate surface modification can easily be done with various chemicals (i.e., 
acid and alkaline treatment), mechanical (mechanical abrasion), and physical treatments 
(i.e., increase temperature). Here we will specifically discuss chemical treatment of the 
silica surface to produce hydroxide sites on the silica surface 
The chemical treatment on silica surface are widely used in electronics and industry 
during cleaning and activating the surface for further modification with silane coupling 
chemistry. However, most of the cleaning and surface treatment techniques require the 
use of strong alkaline treatment (i.e., potassium hydroxide (KOH), sodium hydroxide 
(NaOH)), strong acid treatment (i.e., hydrogen fluoride (HF)). These are highly 
hazardous materials which require special handling and disposal as they are highly 
corrosive and reactive with water. Exploratory experiments were done to functionalized 
the surface of silica particle synthesized from the previous section with strong alkaline. 
However, the total loss of material was observed (Table 3). The treatment was done with 
100 mg of HSi particle in 5 ml of KOH, NaOH, and HCl solution under a vigorous stir. A 
borosilicate glass reflux column was used with the experiment with a heated solvent to 
prevent alkaline fume escapes. The solution was left stirring at 400 rpm at room 
temperature or at 95 oC. After 0.5 or 6 hours, the solution was then allowed to cool down 
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to room temperature then be transferred to a centrifuge tube. Ultracentrifugation (10000 
Gs) was used to collect the particle. The centrifugation was done for 15 minutes, then the 
supernatant was discarded, and the particle was resuspended in 40 ml deionized water. 
The resuspended solution was then centrifuged to remove residual acid or base from the 
particle, repeating three times. The purified particle then dried under vacuum for 48 hours 
before being weight again to determine the recovery rate. The following equation was 
used to calculate the recovery rate in percent: 
%R = 100×W1÷W0
    (2) 
Where %R is recovery rate in percent, W1 is the weight of the particle after treatment, and 
W0 is the initial weight of the particle 
Table 3. Exploratory surface modification condition  
Reactor Concentration Time 
(hours) 
Temperature Approx. 
Recovery 
KOH 
0.1 M (pH 13) 
0.5 25 <40%wt 
6 95 Loss 
1 M (pH 14) 
0.5 25 Loss 
6 95 Loss 
NaOH 1 M (pH 13) 0.5 25 <20%wt 
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6 95 Loss 
10 M (pH 14) 
0.5 25 Loss 
6 95 Loss 
HCl 
0.1 M (pH 1) 
0.5 25 94% 
6 95 87% 
1 M (pH 0) 
0.5 25 95% 
6 95 85% 
The recovery rate was found to be low, and the separation was found to be poor as the 
resulting particle are presumably lost a large amount of mass and integrity with the strong 
alkaline treatment. As an alternative, weaker acid has been utilized in place of a strong 
acid with elevated temperature. HCl treatment was found to mildly affect the particle 
recovery and deemed suitable for surface modification of the nanoparticle. This is further 
supported by the fact that silica material has an isoelectric point at around pH 2, as shown 
in Figure 6. Lower and higher pH value allows the dissolution of silica to occur at 
various speed. The dissolution kinetics of silica was found to be the highest in the 
alkaline range (pH>10) and, though significantly lower, highly acidic condition for the 
acidic range (pH<3). The HF treatment was never attempted as it is generally known that 
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HF reacts more violently to glass than KOH as well as the special hood is required to 
safely handle HF. 
 
Figure 6. Effects of pH value on the silica condensation rate, charge properties, and 
charge density on the surface of the silica species. Reproduced from Ref. 72 with 
permission from The Royal Society of Chemistry. 
2.1.5 Characterization methods 
The most important aspect of utilizing Stӧber method is to ensure minimal crystallinity 
and the ability to effectively control the size and morphology of the resulting particle. 
The particle characterization method is divided into two approaches, which generally 
include physical and chemical analysis. The particle chemical properties are usually 
determined with simple FTIR analysis to ensure the presence of Si-O-Si, Si=O, and Si-
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OH. The FTIR is also utilized to ensure the efficacy of the purification method as well. 
The physical properties of silica particles are generally involved in morphological 
analysis and size distribution analysis. This is to ensure that the particle size and 
morphology are consistent among the sample group. X-ray diffraction was used to ensure 
the amorphous nature of the particles (Figure 7). There were no definitive peaks that are 
correlated with the crystalline SiO2 standard.   The results indicated that all particles 
prepared with the modified Stӧber method are amorphous regardless of the use of 
surfactant and surface modification.  
    
Figure 7. XRD spectra of HSi, AHSi, LSi, and NSi. Pink markings indicate correlated 
crystalline SiO2 crystal spectra, cristobalite 
 
 
Green  = HSi 
Pink  = AHSi 
Orange  = LSi 
Blue  = NSi  
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3 Controlling the Release of Hydrogen Peroxide from 
Catechol-Based Adhesive Using Silica Nanoparticle3 
3.1 Abstract 
Catechol-based bioadhesives generate hydrogen peroxide (H2O2) as a byproduct during 
the curing process. H2O2 can have both beneficial and deleterious effects on biological 
systems, depending on its concentration. To control the amount of H2O2 released from 
catechol-containing polyethylene glycol-based adhesive (PEG-DA), the adhesive was 
formulated with silica nanoparticles (SiNP) prepared with increased porosity and acid 
treatment to increase Si-OH surface content. These SiNP demonstrated increased surface 
area, which promoted interaction with catechol and resulted in increased cure rate, bulk 
mechanical properties and adhesive properties of PEG-DA. Most importantly, SiNP 
demonstrated a 50% reduction in the released H2O2 while improving the cell viability and 
proliferation of three primary cell types, including rat dermal fibroblasts, human 
epidermal keratinocytes, and human tenocytes. Additionally, SiNP degraded into soluble 
Si, which also contributed to increased cell proliferation. Incorporation of porous and 
acid-treated SiNP can be a useful approach to simultaneously modulate the concentration 
of H2O2 while increasing the adhesive performance of catechol-based adhesives. 
 
3 This article was just accepted in ACS Biomaterials Science & Engineering. Copyright 2020 American 
Chemical Society. https://pubs.acs.org/doi/abs/10.1021/acs.biomac.7b01311 
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3.2 Introduction 
Mussels adhere strongly to various surfaces under wet conditions through the secretion of 
adhesive proteins that solidify to form adhesive plaques 16. Catechol moiety found in 
mussels adhesive proteins (MAPs) is one of the main contributors to the interfacial 
binding and crosslinking capabilities of these proteins 82. Catechol-modification of 
natural and synthetic polymers is widely used to create in situ curable bioadhesives with 
strong, wet adhesive properties 83, 84. To activate catechol for crosslinking, catechol needs 
to be oxidized into its reactive quinone form by chemical-mediated (i.e., periodate) or 
enzymatic (i.e., peroxidase) oxidation 85, 86. This is a critical step to initiate cohesive and 
interfacial crosslinking of catechol-containing adhesive. Specifically, periodate is one of 
the most commonly utilized oxidants for initiating curing of injectable biomaterials 87-89. 
Recently, our lab reported that hydrogen peroxide (H2O2) is generated as a byproduct 
during the oxidative crosslinking and curing of catechol-containing adhesive 40. The 
generated reactive oxygen species (ROS) contributed to localized in vitro cytotoxicity, 
promoted antioxidant enzyme expression in primary dermal and tendon fibroblasts, and 
promoted M2 macrophage polarization when the adhesive was implanted subcutaneously. 
Living organisms naturally generate H2O2 as a part of normal wound healing and 
inflammatory response 90-92. The effect of H2O2 on biological systems is also highly 
concentration-dependent. Application of H2O2 at micromolar ranges have been shown to 
accelerate dermal wound healing 93, 94. Additionally, H2O2 is a natural disinfectant 
39. 
However, high levels of H2O2 can destroy healthy tissues, lead to chronic wounds, retard 
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natural healing cascade, and induce tumor formation 38, 95. Given the varying H2O2-
associated biological responses, there is a need to tune the amount of H2O2 released from 
catechol-containing biomaterials according to the application-specific material design. 
H2O2 concentration can be controlled through the use of catalytic metal oxides 
(Al2O3,TiO2), metal ions (Fe
3+, Mn2+, and Cu2+) and enzymes such as catalase 40, 45, 96. 
However, most catalytic metal oxides and ions are not suitable for biological applications 
due to their cytotoxicity, and toxic metal accumulation can occur with prolonged 
exposure 68, 97.  Although catalase readily decompose H2O2 and are suitable for 
biomedical applications, they are limited by elevated costs and issues with stability 98, 99. 
As an alternative, silica (Si) particles and silicate material are economically viable and 
can degrade H2O2 
44. Si materials are more biocompatible when compared to other metal 
oxides 97. Additionally, H2O2 forms a multimember ring complex with Si-OH groups on 
the surface of Si-based material in the presence of water, which helps to further stabilize 
the complex 100, 101. However, Si material decomposes H2O2 at a significantly slower rate 
when compared to other metal oxides 44.Since both degradation and complexation of 
H2O2 on Si material are surface dependent phenomena, a combination of increased 
surface area and surface modification techniques can potentially improve the efficiency 
of silica particles for H2O2 degradation. 
In this work, we prepared highly porous Si particles and further treated these particles 
with strong acid to create a Si-OH-rich surface. We hypothesize that the combination of 
increased surface area and surface chemistry modification can be utilized to modulate the 
34 
release of H2O2 from the catechol-containing adhesive (Scheme 3). A branched 8-armed 
PEG with terminal dopamine moieties (PEG-DA) was used as the model adhesive 64. 
Dopamine resembles the amino acid, DOPA, found in MAPs and contains the catechol 
side chain needed for oxidative crosslinking and interfacial binding. PEG-DA was 
combined with the porous Si particles to form a composite adhesive and the effect of 
particle incorporation on the release of H2O2, the material property of the composite 
adhesive, and the cellular response of primary fibroblast, tenocyte, and keratinocyte was 
investigated. 
 
Scheme 3. Schematic Representation of Mixing PEG-DA with Porous Si Particles to 
Form a Composite Adhesive (A); Catechol Generates H2O2 During Oxidative 
Crosslinking (B); Surface Si–OH Forms Complexation with H2O2 and Water, Resulting 
in H2O2 Degradation (C) 
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3.3 Materials and methods 
3.3.1 Materials 
Phosphate buffer saline (PBS), tetraethyl orthosilicate (TEOS, 99.8%), methanol, ethanol 
(200 proof), sodium hydroxide, cetrimonium bromide (CTAB, 99.9%), hydrogen 
peroxide solution (H2O2, 30%), dimethyl sulfoxide (DMSO), and hydrochloric acid (HCl, 
37%) were purchased from Fisher Scientific (Pittsburgh, PA). Sodium periodate (NaIO4, 
>99.8%) was purchased from Acros Organics (Fair Lawn, NJ). Pierce Quantitative 
Peroxide Assay Kit with sorbitol (ferrous oxidation-xylenol orange (FOX) assay), fetal 
bovine serum (FBS), and Penicillin–Streptomycin (10 U/ml) were purchased from 
Thermo Scientific (Rockford, IL). Rat primary dermal fibroblasts (RDF) were purchased 
from Cells Biologics (Chicago, IL). Dermal Cell Basal Medium, keratinocyte growth kit, 
primary human tenocytes (HT), and primary human epidermal keratinocytes (HEK) were 
purchased from ATCC (Manassas, VA). TransWell® Permeable Supports (12 mm insert, 
12 well plate, 3.0 μ, polycarbonate membrane) were purchased from Corning Costar 
(Pittston, PA). Dulbecco’s modified Eagle’s medium (DMEM; with 4.5 g/L glucose and 
glutamine, without sodium pyruvate), and trypsin–EDTA (0.05% Trypsin/0.53 mM 
EDTA in Hank’s balanced salt solution) were obtained from Corning Cellgro (Manassas, 
VA). Tenocyte Growth Medium was purchased from Zenbio (Research Triangle Park, 
NC).  Polyfreeze®, phosphate-buffered saline (PBS, BioPerformance certified, pH 7.4), 
bovine liver catalase, Trichrome Stain (Masson’s) Kit, Bouin’s solution, and Weigert’s 
iron hematoxylin solution were purchased from Sigma-Aldrich (St. Louis, MO). 3-(4,5- 
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dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 98% (MTT) was purchased from 
Alfa Aesar (Ward Hill, MA). Anti-Ki-67 antibody (ab15580), goat anti-rabbit IgG H&L 
(Alexa Fluor 488) (ab150077), and goat anti-rabbit IgG H&L (Alexa Fluor 647) 
(ab150079) were purchased from Abcam (Cambridge, MA). 4,6-Diamidino-2-
phenylindole (DAPI) was obtained from Invitrogen (Grand Island, NY). PEG-DA was 
prepared following previously published protocols using an 8-armed PEG (MW=20 kDa, 
JenKem USA, TX) 64 
3.3.2 Synthesis of Silica Particles  
Nonporous silica nanoparticle (NSi) was prepared using a modified Stöber method 
without surfactant 64. Mesoporous silica particles with low (LSi) and high (HSi) porosity 
were prepared using the same Stöber method with CTAB as a surfactant. The silica 
precursor solution was prepared by mixing 0, 9.4, or 18.8 g of CTAB (for NSi, LSi, and 
HSi, respectively) into 500 ml of ethanol and water mixed solution (2:1 v/v ratio) and 
vigorously stirred (15 min at 400 rpm) at 55 °C using a heating manifold and maintained 
at pH 11 with dropwise addition of 0.1M NaOH. Then, 10 ml of TEOS solution was 
added dropwise into the reaction mixture at a rate of roughly 300 μl s−1 while stirring at 
1000 rpm. The mixture was left stirring for another hour at 55 °C. 0.1 M HCl was added 
dropwise to the reaction mixture to neutralize its pH, which was further stirred for 
another 15 minutes at room temperature. The reaction mixture was centrifuged at 10,000 
kGs then washed 3 times with methanol, ethanol, and deionized (DI) water. The particles 
were dried under vacuum for 24 hours and sifted using American Society for Testing and 
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Materials (ASTM) 450 (32 μm) sifters to remove any large contaminants and aggregates. 
The yield of the NSi, LSi, and HSi particles was 75%, 68%, and 66%, respectively.  
3.3.3 Silica Particle Modification 
Acid-treated HSi (AHSi) particles were prepared using a modified version of a previously 
developed acid activation technique 79. HSi (1 g) was resuspended in 200 ml of ethanol, 
then 2 ml of 12 M HCl was added into the mixture. The mixture was heated at 90 oC with 
continued stirring under a N2 environment with a reflux column for 12 hours. NaOH 
(17.6M) was added dropwise to neutralize the solution pH to 6.5 and then was further 
stirred for 30 minutes at room temperature. The mixture was centrifuged at 10,000 kGs at 
4oC, and the particles were washed 3 times with methanol, ethanol, and then DI water. 
The particles were dried under vacuum for 24 hours and sifted through ASTM 450 (32 
μm) sifters. The yield of these particles was approximately 33%. The particles were 
dehydrated in a 200°C oven over a bed of potassium carbonate desiccant for 12 hours 
before backfilling with N2 gas to remove all moisture. 
3.3.4 Silica Particle Surface and Composition Characterization 
The total surface area of the particle was calculated using the Brunauer-Emmett-Teller 
(BET) model. A BET surface area Micromeritics ASAP 2000 sorptometer 
(Micromeritics) was utilized to measure the surface areas of silica particles by nitrogen 
adsorption at liquid-nitrogen temperature (-196.15oC). The samples were degassed at 120 
°C for 12 hours before the surface measurement. The total surface area was determined 
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by the physical absorption of N2 gas on to the particle surface 102. A FEI 200kV Titan 
Themis. Scanning Transmission Electron Microscope (S-TEM) was used to visualize the 
morphology of the particle, and Energy-dispersive X-ray spectroscopy (EDS) was used to 
measure the elemental (Si and O) content of the particle. ImageJ program (NIH) was used 
to measure the particle size from TEM images. 
3.3.5 Adhesive Formation 
The PEG-DA adhesive hydrogels were prepared following a previously published 
protocol 64. The adhesive was prepared by mixing equal volume of the adhesive precursor 
solution (300 mg ml−1 of PEG-DA in 2xPBS at pH 7.4) and NaIO4 solution (54.5 mM in 
DI water). The final concentration of PEG-DA was 150 mg ml−1. The Si particle 
incorporated composite adhesives were formed in a similar manner with the addition of 
20 wt% of the corresponding Si particles into the PEG-DA precursor solution. The final 
concentration of the particles in the composite adhesive was 10 wt%. The final NaIO4 to 
dopamine molar ratio was 0.5 for all adhesive formulations. To determine the gelation 
time of the hydrogels, 200 μl of the mixed solution was introduced into a 1.5 ml 
scintillated vial. The time it took for the mixture to cease flowing in a tilted vial was 
determined as the cure time 27. Unless specified otherwise, the adhesive was cured in 
between two borosilicate glass sheets with a silicon rubber mold (width = 4 cm, height = 
4 cm, thickness = 1.5 mm) for 24 hours. The cured adhesive sheet was cut into disk 
shapes using a tissue punch with a diameter of 10 mm to create hydrogel disks with a 
diameter of 10 mm and a thickness of 1.5 mm. The hydrogel disks were further 
39 
equilibrated in PBS (pH = 7.4) before additional characterization. Adhesive formulations 
containing NSi, HSi, and AHSi are denoted as PEG-NSi PEG-HSi and PEG-AHSi, 
respectively. 
3.3.6 Physical and Chemical Characterization of the Adhesive 
Samples were freeze-dried for at least 48 hours and characterized using Fourier transform 
infrared (FTIR) spectroscopy (Perkin Elmer Spectrum One with DLATGS detector) with 
a single bounce attenuated total reflectance (ATR) unit (PIKE Technologies, diamond 
internal reflection element (IRE) GladiATR). The scan rate was set at 800 scans/minutes 
with a resolution of 1 cm-1. The FTIR experiments were done at ambient conditions. In 
vitro degradation behavior of adhesive disks (n = 3) was determined by incubating the 
samples in 5 ml of PBS (pH = 7.4) at 37 °C and tracking their remaining mass (Mr) over 
8 weeks. The hydrogel discs were equilibrated overnight before the degradation 
experiment started to ensure stable initial weight. The discs were then dried under 
vacuum for at least 48 hours. Dry weight was used to determine the degradation rate 
using the following equation: 
    (3) 
where M0 and Mt are the initial mass of the adhesive and its mass after incubation for a 
given amount of time, respectively 86. The PBS solution was replaced every 7 days. 
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To determine the concentration of soluble silica released from the adhesive, fully cured 
samples (n = 3 for each group) were incubated in 1 mL of 1xPBS (pH 7.4) in a 
polystyrene container for 2 weeks. The PBS extracts were diluted by adding deionized 
water to 10 mL in a polystyrene centrifuge tube prior to testing. The diluted extract was 
then evaluated for silica content using inductively coupled plasma optical emission 
spectroscopy (ICP-OES; Perkin Elmer Optima 7000DV) utilizing a cross-flow nebulizer 
(plasma 15 mL min-1, auxiliary 0.2 mL min-1, nebulizer 0.80 mL min-1, RF power 1,350 
W, pump speed 1.5 ml min-1) Instrument Calibration Standard 3 (Perkin Elmer) was 
used to create the calibration standards. Three samples per formulation were collected 
and each sample was analyzed three times. 
An oscillatory rheometer (Discovery Hybrid Rheometer HR2; TA instruments, Newcastle 
DE) was used to determine the storage (G′) and loss (G′′) moduli of the cured adhesive 
samples. Strain sweep experiment was performed by subjecting disk-shaped samples (n = 
3) to a strain of 0.01–100% at a frequency of 0.1 Hz using a parallel plate setup at 
ambient temperature. The gap distance was set at 87.5% of the thickness of each 
individual hydrogel, to ensure sufficient traction during the rheometry experiment. 1 ml 
of pH 7.4 PBS was introduced around the composite adhesive to prevent dehydration. 
Lap shear adhesion test was performed using bovine pericardium while following a 
previously published protocol according to ASTM standard F2255-05 64. Strips of 
pericardium tissues (2.5 cm x 2.5 cm) were kept moist in PBS. 100 μl of PEG-DA 
precursor solution and NaIO4 solution with and without Si particles were mixed in a 
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scintillated glass vial before being transferred on to the surface of the tissue. Another 
piece of pericardium tissue was applied over the adhesive to create an adhesive joint 
(overlapping area of 2.5 cm2), which was compressed with a 100-g weight for 15 min. 
The adhesive joint was submerged in PBS (pH = 7.4) at 37 °C for overnight prior to 
testing. A digital caliper was used to measure the dimensions of the overlapped area of 
each adhesive joint before testing. The fixation of the tissue pieces on to the test stage 
was done with serrated metal grips to ensure sufficient traction. An Electroforce® 
machine (Bose Electroforce Group, MN) was used to pull apart the adhesive joint to 
failure at a rate of 0.1 mm s−1. The adhesive strength was determined by the maximum 
load divided by the initial overlapped area of the adhesive joint. 
3.3.7 In vitro Cell Viability 
The cell viability experiment was performed following a previously published protocol 
with modifications 64. A quantitative MTT assay was used to determine the relative 
viability of cells exposed to the adhesives and their extracts, while following ISO 10993-
5 guideline 103. Microfiltration was utilized as a sterilization method. The PEG-DA 
precursor solution and NaIO4 solution were filtered with a 0.2 μm polyethersulfone 
syringe filter (VWR International, USA). The particles were sterilized using ethylene 
oxide in a microcentrifuge tube. Adhesive extracts were prepared by forming hydrogel 
discs (diameter =10 mm and thickness = 1.5 mm, n=3) as described above, followed by 
incubating each disc in 1 ml of cell-specific culture medium for 24 hours at 37oC. RDF, 
HEK, and HT were suspended in their cell-specific culture medium. Cell suspensions 
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were then added to a 96-well microculture plate at a density of 1,000, 2,000, and 2,000 
cells/well, respectively. Varying amount of culture medium was added to each well to 
maintain the culture medium volume of each well to 100 μl. The cells were incubated in a 
humidified incubator (37 °C, 5% CO2) for 24 hours to obtain a confluent monolayer of 
cells. A light microscope (Olympus, PA) was used to observe the monolayer to ensure the 
confluence level. Then, the medium was replaced with 100 μl of the adhesive extract. 
After incubation for 24 hours, the medium was removed and replaced with 50 μl of MTT 
solution (1 mg ml−1 in pH 7.4 PBS) and further incubated for another 2 hours. After the 
2-hour incubation, the MTT solution was replaced by 100 μl of DMSO to dissolve 
formazan crystals. The absorbance of each well was measured at 570 nm (reference 650 
nm) using a Synergy HT Multi-Mode Microplate Reader (BioTek, USA). The relative 
cell viability was calculated by dividing the average absorbance value of the sample from 
that of cells cultured in the culture medium after subtraction of the absorbance 
background of untreated culture medium 6. 
3.3.8 In vitro Cell Proliferation 
All experiments were performed with a Transwell set up to ensure the continuous 
exposure of the cells to the composite adhesive. Ki-67 and DAPI fluorescence staining 
were performed to analyze the proliferation of cells exposed to the adhesive placed in 
Transwell inserts. NaIO4 (160 μl) and sterile adhesive precursor solution (1:1 v/v) was 
introduced into a circular silicone mold with a dimension of 10 mm x 1 mm. The mixed 
solution was left to gel for 5 minutes before being transferred into Transwell inserts. 
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RDF, HEK, and HT were seeded into 12-well Transwell-compatible plates at a density of 
5,000, 20,000, and 20,000 cells/well, respectively. The cells were incubated (37 °C, 5% 
CO2) for 24 hours to obtain a 60-75% confluent monolayer of cells. A light microscope 
(Olympus, PA) was used to observe the monolayer to ensure the confluence level. The 
culture medium was removed before the Transwell inserts were introduced. Fresh 
medium (1ml) was added. Transwell inserts were removed after 24 hours of incubation 
along with the culture medium. Cells were fixed using a 1% paraformaldehyde solution 
for 15 minutes and permeabilized using a 1% Tween20 solution. The solution was 
removed, and the cells were washed with a treatment solution of 0.1% Triton X-100. 
After the treatment solution was removed, the primary Ki-67 antibody solution (1:1,000) 
was introduced and incubated at room temperature for 45 minutes before being washed 3 
times by the washing medium for 5 minutes each. The washing medium was removed, 
then Alexa Fluor 488 green fluorescence stain was introduced for 45 minutes before 
being wash 3 times with the washing medium for 5 minutes each. The washing medium 
was removed, and the DAPI solution (1:1,000) was introduced for 5 minutes before being 
washed 3 times using the washing medium for 5 minutes each. The washing medium was 
removed, and the cells were analyzed via fluorescence microscopy using an automated 
microscope (EVOS, Fisher). Ki-67 positive cells and cell nuclei fluoresced green and 
blue, respectively. The total cell counts were averaged from all 27 images of each 
formulation. 
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3.3.9 Statistical analysis 
Statistical analysis was performed using SigmaPlot 14 software. One-way analysis of 
variance (ANOVA) with Tukey’s HSD analysis and Student’s t-test were performed for 
comparing means of multiple groups and two groups, respectively, using a p-value of 
0.05.  
3.4 Results and discussion  
3.4.1 Characterization of Si Particles 
S-TEM was used to determine the particle size and morphology of each type of silica 
nano particle (SiNP) (Figure 8). NSi appeared dark with solid-like morphology. On the 
other hand, LSi, HSi, and AHSi were prepared with a quaternary ammonium surfactant, 
CTAB, and appeared lighter in color with porous structures. The particle size of NSi 
averaged around 660.6±52.63 nm, which was larger when compared to the porous 
particles (528.08±34.25 nm and 422.24±23.24 nm for LSi and HSi, respectively) (Figure 
9). This result suggests that the incorporation of CTAB reduced the final particle size by 
reducing the microbubble size in the reaction solution through surface energy reduction 
72, 78. In the case of AHSi, acid treatment did not significantly affect its particle size when 
compared to HSi. 
BET-N2 sorption measurement demonstrated that the addition of CTAB during synthesis 
increases the total surface area of the particle (Figure 10). NSi exhibited the smallest 
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surface area (13.72±0.26 m2/g) among all the SiNP, while the porous SiNP exhibited an 
order magnitude higher surface area (256.58±0.71, 327.45±5.51, and 386.75±5.19 m2/g 
for LSi, HSi, and AHSi, respectively). CTAB and other surfactants introduce porosity 
into the silica particle, creating a mesoporous particle as a result 72, 78. With an increasing 
amount of CTAB, the porosity increased as more porogen were introduced. Acid 
treatment after particle synthesis also significantly increased the pore volume in AHSi. 
The effect is directly linked to the removal of silicate groups from the particle surfaces as 
colloidal silicates during acid treatment 104. Hence, the newly exposed surface formed a 
multitude of hydroxylated silica groups under acid treatment 104, 105. S-TEM EDS analysis 
indicated that the composition of silica to oxygen ratio (S:O) decreased when HSi was 
treated with acid. The higher oxygen (O) content in AHSi indicated an increase in 
oxygen-silicon groups (i.e., Si=O, Si-OH, Si(OH)2, and Si(OH)3) on the surface of the 
particle. 
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Figure 8. STEM images of non-porous silica nanoparticle (NSi) (A), porous silica 
nanoparticle (LSi) (B), highly porous silica nanoparticle (HSi) (C), and acid-heat treated 
highly porous silica nanoparticle (AHSi) (D). Scale bars are 50 nm. 
 
Figure 9. Particle size distribution of silica particles. * p<0.05 when compared to each 
other. 
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Figure 10. Surface area of Si particles determined using BET N2 sorption. *p<0.05 when 
compared with each other.  
3.4.2 Effect of Silica Particle on H2O2 Decomposition  
100μM of H2O2 was mixed with each type of SiNP, and the change in the concentration 
of H2O2 was evaluated using FOX assay (Figure 11). The concentration of H2O2 is set 
to mimic the H2O2 concentration in skin tissue after an injury (50-100 µM) 106. When 
treated with NSi, the relative concentration of H2O2 decreased slowly and over 80% of 
the initial amount of H2O2 remained even after 72 hrs of incubation. Increasing particle 
porosity and acid treatment further decreased H2O2 concentrations (62.26±1.05 and 
35.12±4.05 μM at 72 hrs for HSi and AHSi, respectively). The accelerated degradation of 
H2O2 resulted from a combination of H2O2-Si-OH complexation on the surface and mild 
catalytic effect of silica on H2O2 degradation 
44, 101. As a result, the increase in surface 
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area of the silica particle through increased porosity combined with the change in surface 
chemistry led to a faster reduction in H2O2 concentration. However, these SiNP were not 
as effective as that of catalase, which completely decomposed H2O2 within 1 hr. 
 
Figure 11. Relative H2O2 concentration after incubation with Si particles or 1000 units of 
catalase at pH 7.4 and 37oC. The starting H2O2 concentration was 100 µM. 
3.4.3 Preparation and Characterization of Composite Adhesives 
Catechol moieties were oxidized by NaIO4, resulting in the crosslinking and 
polymerization of catechol. PEG-DA is end-modified with catechol and oxidative 
crosslinking of catechol resulted in the curing of PEG-DA. The gelation time for PEG-
DA averaged around 36 s (Figure 12), when the precursor solution mixture stopped 
flowing in a tilted vial. Si particles were incorporated into PEG-DA to form composite 
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adhesives. Incorporating NSi reduced the gelation time slightly (31±0.82 s for PEG-NSi). 
The PEG network likely formed physical entanglement with SiNP and catechol moiety 
can form hydrogen bonds with Si-OH. These interactions contributed to the reduction in 
gelation time as a result of forming new crosslinking points within the adhesive network. 
Incorporating porous Si particles further reduced the gelation time (22±0.82 s and 
21±0.82 s for PEG-HSi and PEG-AHSi, respectively). Increased particle surface area 
likely increased the number of interactions between catechol and the particle surface, 
effectively increased the rate of gelation. 
 
Figure 12. Gelation time of PEG-DA and its composite containing different silica 
particles. *p<0.05 when compared to PEG-DA. **p<0.05 when compared to PEG-DA 
and PEG-NSi. 
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ATR-FTIR spectra of the Si particles revealed Si–O-Si peaks at 1065 cm-1 (Si–O 
stretching) and 800 cm-1 (Si–O bending) as well as Si–OH bending peak at 950 cm-1 
(Figure 13). The Si–OH peak intensity was noticeably increased for AHSi, which is in 
agreement with the EDS result. The spectrum of PEG-DA exhibited characteristic peaks 
corresponding to PEG (–C–O–C– at 1000–1150 cm−1, –CH2– at 2880 cm−1), carbonyl 
group in ester bond (1729 cm−1) and aromatic ring in catechol (1400–1500 cm−1) 64. 
Incorporating the Si particles resulted in shifts over the peaks associated with Si–O–Si 
(1030 cm-1 and 790 cm-1) and Si–OH (960 cm-1), confirming the presence of Si 
particles in the composite adhesives. The shifts may be attributed to the overlapped signal 
from PEG ether peaks (–C–O–C– at 1000–1150 cm-1) 107.  Additionally, the peaks 
associated with silica particle demonstrated reductions in intensity which indicated 
hydrogen bond formed between the Si–OH and catechol or the oxygen atom of –C–O–C– 
of PEG backbone. 
Oscillatory rheometry was utilized to assess the effect of Si particles on the viscoelastic 
properties of the adhesives (Figure 14). For all adhesive formulations, the storage 
modulus (G’) values exceeded those of the loss modulus (G”), indicating that these 
adhesive were chemically crosslinked 108.  G’ values for PEG-DA at the linear 
viscoelastic range were measured to be approximately 4.9 kPa, and adding 10 wt% NSi 
particles significantly increased G’ (5.5 kPa for PEG-Si; p < 0.05 when compared PEG-
DA). This increase in the stiffness of the adhesive network is potentially due to increased 
interactions between the Si particles and PEG-DA network 64, 86.  Additionally, 
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incorporation porous Si particles further increased G’ values (5.9 and 6.2 kPa for PEG-
HSi and PEG-AHSi, respectively; p < 0.05 when compared PEG-DA and PEG-NSi).  
 
Figure 13. FTIR spectra of the Si particles (A) and PEG-DA containing the Si particles 
(B). Dash lines indicate (from left to right for A and B) Si-O-Si (1065 and 1030 cm-1), Si-
OH (950 and 960 cm-1), and Si-O-Si (800 and 790 cm-1) peaks. 
Wavenumber (cm
-1
)
600800100012001400160018002000
T
ra
n
s
m
it
ta
n
c
e
 (
%
)
NSi
LSi
HSi
AHSi
Wavenumber (cm-1)
600800100012001400160018002000
T
ra
n
s
m
it
ta
n
c
e
 (
%
)
PEG-AHSi
PEG-HSi
PEG-DA
PEG-NSi
A 
B 
52 
Additionally, the decrease in the particle size and increase in the effective surface area 
also contributed to the increased stiffness of PEG-DA composites 55.  This suggests that 
increased particle surface area likely increased the number of interactions between 
 
Figure 14. Storage (A) and loss (B) modulus of PEG-DA and its composite containing 
different silica particles.  
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catechol and the particle surface, effectively increased mechanical property of the 
composite adhesive. G” values for SiNP-containing composite adhesive were 
significantly higher when compared to that of PEG-DA. This result indicates that 
incorporating SiNP increased viscous dissipation properties likely through the formation 
of physical interactions within the adhesive network 64, 86. 
Bovine pericardium was used as the test substrate in lap shear adhesion test (Figures 15). 
The adhesive strength for PEG-DA was measured to be 3.84±0.60 kPa. While it is 
difficult to compare reported values from other PEG-catechol adhesives due to 
differences in the method and substrate use, the values reported here are well within the 
range of 103-104 Pa which is similar to the storage modulus reported elsewhere for PEG-
catechol adhesives 64, 86. This value increased with the addition of 10 wt% SiNP 
(4.97±1.00, 6.87±1.35, and 7.35±1.01 kPa for NSi, HSi, and AHSi, respectively). The 
addition of nanoparticles has been previously found to increase the adhesion strength in 
catechol-based adhesives 64, 86. Measured lap shear adhesion strength for PEG-AHSi was 
the highest. The increased surface area in these particles likely increased the availability 
of Si that can interact with catechol found in PEG-DA for forming hydrogen bonding. 
This resulted in an increased bulk mechanical property and subsequently the adhesive 
property. Similarly, elevated bulk mechanical property for PEG-HSi and PEG-AHSi 
(Figure 14) also contributed to enhanced measured lap shear strength. 
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Figure 15. Lap shear adhesion strength of PEG-DA and its composite containing 
different silica particles using bovine pericardium as the test substrate. *p<0.05 when 
compared to PEG-DA. **p < 0.05 when compared to PEG-DA and PEG-NSi 
In vitro degradation of the adhesive was studied by tracking the change in the dry mass of 
the fully crosslinked samples (Figure 16). PEG-DA degraded completely by week 8, 
which is in agreement with PEG-catechol adhesive with ester linkages 64. Incorporating 
Si particles delayed the degradation of the composite adhesives. For PEG-AHSi, 
approximately 40% of its original dry mass remained even after 8 weeks of degradation, 
and the degradation rate was found to be approximately 8% per week. The delayed 
degradation is likely a result of an increase in mechanical integrity as well as localized 
pH reduction surrounding the silica particle 64, 86. As amorphous silica particle degrades, 
soluble silica species in the form of orthosilicic acid is released 109, which contributed to 
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the delayed degradation of SiNP-containing adhesive. PEG-DA degrades trough the 
hydrolysis of the ester linkage between the glutaric acid and PEG 110, and the hydrolysis 
rate of ester bond is reduced in a mildly acidic pH 111. 
ICP-OES was used to analyze the concentration of soluble Si released from Si particles 
(Figure 17). Soluble Si can be derived from hydroxylated silicon surface in the form of 
orthosilicic acid. PEG-NSi and PEG-HSi released less than 10 mg/L of Si over 24 hours, 
whereas PEG-AHSi released nearly 3 folds higher Si over the same period of time. This 
increased level of soluble Si suggests that acid treatment altered the surface chemistry of 
Si particle to form the more hydrophilic Si-OH functional group. We speculated that the 
nature of our particle synthesis resulted in noncrystalline particles which can react 
promptly to formed surface groups of Si-OH when being exposed to oxidizing species or, 
in some cases, deionized water 112. Additionally, the degradation rate of the silica particle 
was reported to be highly dependent on surface functional groups including SiOH, their 
protonated form (SiOH2+), and their deprotonated form (SiO-) 113.  As a result, the 
increases in degradation products, soluble silica or silicic acid, were expected as the 
SiOH surface functional groups were increased after the acid treatment as demonstrated 
by the EDS results. 
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Figure 16. Normalized residual weight of PEG-DA and its composite containing 
different silica particles. The samples were incubated in PBS (pH 7.4) at 37 °C. *p<0.05 
when compared to all other groups 
PEG-DA continuously generated H2O2 and reaching a maximum concentration of nearly 
60 μM 6 hours after mixing the precursor solutions (Figure 18). Although PEG-DA 
cured around 36 s (Figure 12), catechol can continue to polymerize to form oligomers 
consisted of 6-7 catechol residues and generate H2O2 during catechol oxidative 
crosslinking 40, 85. The oxidation of catechol produced superoxide which can participate to 
further oxidize other catechol groups. The generated superoxide can further oxidize 
catechol or interact with protons (H+) in the surrounding media to form H2O2. After 
catechol ceased to undergo oxidative crosslinking, PEG-DA ceased to generate H2O2, and 
the amount of H2O2 released from the adhesive decreased 
40. Adding SiNP had minimal 
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Figure 17. Soluble Si content of PEG-DA and its composite containing different Si 
particles after 24 hour incubation in complete medium at pH 7.4 and 37oC. * p<0.05 
when compared to all other groups  
effect on the measured H2O2 concentration. However, adding the porous HSi and acid-
treated AHSi drastically reduced the amount of the released H2O2 (44.27±1.50 μM and 
34.30±1.83 μM for PEG-HSi and PEG-AHSi, respectively, at 6-hour time point). This 
result indicated that incorporating Si particles with enhanced surface area and surface 
modification can effectively reduce the amount of H2O2 generated during catechol 
crosslinking. 
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Figure 18. H2O2 concentration of PEG-DA and its composite containing different Si 
particles. * p<0.05 when compared to all other groups. ** p<0.05 when compared to 
PEG-DA and PEG-NSi 
3.4.4 Effect of Incorporating Si Particle in PEG-DA on Cellular Response  
The effect of incorporating Si particles into PEG-DA on the cell viability and 
proliferation of primary fibroblast, keratinocyte, and tenocyte was investigated. For 
fibroblast and tenocyte, PEG-DA reduced the relative cell viability to around 85% when 
compared to the media control (Figure 19), and the incorporation of AHSi particle 
significantly improves cell viability (> 95%). This is presumably due to the reduced 
concentration of H2O2 released from PEG-AHSi. Interestingly, there was no difference in 
the cell viability for keratinocyte when exposed to the three different adhesive 
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formulations. Keratinocytes are more resistant to oxidative stress and can actively 
degrade ROS 114.  Keratinocyte viability was high even when it was exposed to PEG-DA, 
which generated the highest concentration of H2O2 among the adhesive formulation 
tested. An MTT assay was used to determine cell viability and normalized by cells that 
were exposed to the cell culture medium. The result demonstrated that keratinocytes, 
which were exposed to the adhesive extracts, had higher relative MTT signal when 
compared to control. This increase in relative MTT signal was not observed in RDF and 
HT. Specifically, keratinocytes exposed to the 3 adhesive formulations exhibited 30% 
higher MTT absorption than the control cells, indicating that exposure to H2O2 likely 
increases keratinocyte proliferation 114. 
Ki-67 expression was utilized to determine the number of proliferating cells after 
exposure to the adhesive formulation (Figure 20). For all cell types tested, cells exposed 
to PEG-DA exhibited the lowest fraction of proliferating cells, which increased with the 
incorporation of porous Si particles. Cells exposed to PEG-AHSi exhibited the highest-
level cell proliferation, a 3-4-fold increase when compared to cells exposed to PEG-DA. 
Among the particles fabricated, AHSi releases the highest amount of soluble Si (Figure 
10), which contributed to the observed increase in cell proliferation 76, 115. The cellular 
proliferation effect was not localized (Figure S6), potentially due to the rapid diffusion of 
soluble Si in the culture 116. Additionally, AHSi also significantly reduced the 
concentration of H2O2 generated by catechol, which effectively promoted cell survival. 
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Taken together, SiNP with increased porosity and modified surface chemistry was 
utilized to control H2O2 generated during the curing process of catechol-based adhesive. 
SiNP functioned as a filler in the composite adhesive and effectively increased its 
crosslinking density and materials property. Most interestingly, these particles and their 
composites were nearly chemically identical. However, the cellular response to these 
materials was drastically different. Specifically, tenocytes are typically exposed to an 
environment with low oxidative stress due to ischemic localized tissue compression in 
tendons as well as the lack of vascularization in the native tissue 117, 118.  Exposure to 
reduced concentrations of H2O2 increased the cell viability and proliferation of tenocyte. 
On the other hand, keratinocytes can actively degrade ROS, and H2O2 has been 
previously demonstrated to promote keratinocyte proliferation and migration 114. 
Keratinocyte demonstrated cell viability that was independent of the concentration of the 
released H2O2. Our study points to the need to control H2O2 concentration depending on 
the desired application. Depending on the biological system, the response to the released 
H2O2 will likely be significantly different. 
When compared to catalytic metal oxide and ions, SiNP provides a biocompatible 
alternative to decompose H2O2. Although SiNP demonstrated reduced capability in 
degrading H2O2 when compared to catalase, SiNP reported here provided added benefits 
besides catalyzing the degradation of H2O2. Degradation product of SiNP mainly consists 
of silicic acid, which are present in various tissues (e.g., bone and tendon) or organs (e.g., 
liver and kidney) 119, 120. Silicic acid can also promote collagen synthesis and osteoblast 
differentiation in vitro 121, 122. Soluble Si has also demonstrated the ability to promote cell 
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Figure 19. MTT signal relative to culture medium control for primary rat dermal 
fibroblast (A), human epidermal keratinocytes (B), and human tenocyte (C) after 
incubated with PEG-DA and its composite containing different Si particles for 24 hours 
in complete medium at pH 7.4 and 37oC. *p<0.05 when compared to PEG-DA. ** 
p<0.05 when compared to all other groups, respectively. 
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Figure 20. Percentage of cells that were Ki-67 positive and the total cell count for 
primary rat dermal fibroblast (A), human epidermal keratinocyte (B), and human 
tenocyte (C) exposed to adhesive for 24 hours in complete medium at pH 7.4 and 37oC. * 
p<0.05 when compared to all other groups 
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proliferation and migration, and accelerate dermal wound closure 76, 115. PEG-AHSi 
released the highest amount of soluble Si, which contributed to the highest Ki-67 
expression in all three cell types that we tested. The incorporation of surface-treated SiNP 
is potentially a facile and economical method to control H2O2 concentration while 
improving the biocompatibility and adhesive performance of a PEG-based adhesive. 
Additionally, by better controlling the concentration of H2O2 generated during the 
crosslinking process of catechol-based adhesive, it can potentially enable these adhesives 
for cell-engineering or cell delivery applications involving cells that are sensitive to 
elevated oxidative stress.  
3.5 Conclusions  
In conclusion, increased porosity and acid treatment of SiNP greatly enhanced its ability 
to decompose H2O2. When these SiNP were incorporated into PEG-DA, the amount of 
released H2O2 was also significantly reduced. Additionally, incorporating these particles 
increased lap shear adhesion strength, storage modulus, and altered the adhesive 
degradation behavior. Furthermore, these SiNP increased the cell viability of primary 
dermal fibroblasts and tenocytes, and the proliferation rate of these cells and 
keratinocytes. Ultimately, incorporation of porous and acid-treated SiNP can be a useful 
approach to simultaneously modulate the concentration of H2O2 while increasing the 
adhesive performance of catechol-based adhesives.  
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4 Systemic Study of Silica Particle-Catechol Composite 
Adhesive on Dermal Wound Repair in Mice3 
4.1 Abstract 
The robust optimum design of the experiment was utilized to pinpoint catechol-based 
polyethylene glycol (PEG) adhesive and their composite for the dermal wound healing 
specific application. Experimental results confirmed that the incorporation of an acid-
treated silica particle (AHSi) could reduce hydrogen peroxide byproduct of the catechol-
based adhesive in a predictable range. The full-thickness dermal wound repair model in 
mice was performed to study the effect of polymer architecture and incorporation of 
AHSi. 6-arm PEG adhesive (PEG-D6) with the H2O2 producing nearly 100 µM was 
shown to shorten the time required for wound closure by half. The addition of AHSi was 
found to improve the tissue remodeling while maintaining the effective wound closure 
speed observed in the PEG-D6. Ultimate, tissue-specific adhesive architecture and 
composite formulation can be design to achieve the desired outcome, combing 
accelerated wound healing with better wound remodeling.         
4.2 Introduction 
Wound healing is one of the most commonly studied topics in biomedicine. A number of 
approaches have been proposed over the decades of biomedical material development to 
treat tissue-specific wound healing. These approaches may include scaffolding, drug and 
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protein delivery, tissue engineering and transplantation, and bioactive dressing. Wound 
dressing required means to adhere to skin or target tissue to provide structural support or 
to cover the wound entirely. However, there are challenges when dealing with an open 
wound or topical wound, which involves fluid management, wound irrigation, 
antimicrobial, and sufficient material strength. Particularly, the most wound dressing will 
not perform well in a wet environment 123-125.  
Catecholic amino acid, 3,4–dihydroxyphenylalanine (DOPA), are naturally contained 
within mussels adhesive proteins, which enables them to bind underwater surfaces 123, 126. 
While oxidized, DOPA is capable of forming interfacial covalent bonds with organic 
surfaces (e.g., tissues), making an interesting candidate for wound dressing under wet 
environment  127, 128. Catechol can be functionalized into synthetic polymers (i.e., 
polyethylene glycol) to produce strong, wet adhesive properties for various applications 
129-131.  
Catechol adhesive must undergo oxidation in order to crosslink and adhere to surfaces 132-
135. However, while doing so, the adhesive was found to release chemical byproduct in 
the form of superoxide and hydrogen peroxide (H2O2) 
36, 40, 136. The amount of superoxide 
and H2O2 was measured to be between 10-10
4 µM range, depending on their architecture 
36. Recently, we have demonstrated that the incorporation of an acid-treated silica particle 
(AHSi) can reduce H2O2 concentration from a polyethylene glycol-based catechol 
adhesive. The composite adhesive demonstrates improved stiffness, adhesion strength, 
and improved cellular response in vitro. The biological response was investigated with 
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fibroblast, keratinocyte, and tenocyte 136. These cell types are known to react to H2O2 and 
oxidative stress differently. Keratinocyte is known to demonstrate high resilience toward 
H2O2 and oxidative stress following by moderately H2O2-tolerate dermal fibroblast and 
non-H2O2 tolerant tenocyte 
35, 40, 118. Hence, the ability to modulate H2O2 concentration is 
required for the optimum biological response when targeting such cells and tissues.     
To tune the H2O2 concentration of the adhesive, we introduce a bioactive silica particle, 
AHSi, into the adhesive network. The architecture of the adhesive network (i.e., different 
branch structure, crosslinking density, etc.) is known to inherently affect the H2O2 
concentration 40, 136. We have demonstrated previously that the incorporation of AHSi 
particle effectively reduces H2O2 concentration by 50% in an 8-arm polyethylene glycol 
(PEG) based adhesive, potentially due to the surface interaction between silanol group on 
the particle surface with H2O2 under wet condition 
136. We hypothesized that variation of 
PEG adhesive architecture would allow for better control over H2O2 generation while 
maintaining the adhesive properties of the composite. The resulting composite adhesive 
should also demonstrate a better biological response as a result.  
To this end, we systematically study the varying catechol adhesive composite containing 
AHSi. Gelation time, H2O2 concentration, and adhesive strength of the adhesive and their 
composites have been investigated. Full-thickness dermal wound repair mice model study 
was carried out to determine the effect of different adhesive architecture as well as the 
effect of AHSi addition on dermal wound healing. 
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4.3 Materials and methods 
4.3.1 Materials  
4-arm, 6-arm, and 8-arm Polyethylene glycol (10kDa, 15 kDa, and 20 kDa, respectively, 
Jenkem, TX, USA), Sodium periodate (NaIO4, >99.8%) were obtained from Acros 
Organics (Fair Lawn, NJ). Phosphate buffer saline (PBS), tetraethyl orthosilicate (TEOS, 
99.8%), ethanol (200 proof), sodium hydroxide, and acetic acid (Glacier) were purchased 
from Fisher Scientific Co. (Pittsburgh, PA). Histology mounting medium Polyfreeze, 
Trichrome Stain (Masson) Kit, Bouin's solution, and Weigert's iron hematoxylin solution 
were purchased from Sigma-Aldrich (St. Louis, MO). goat anti-rabbit IgG H&L (Alexa 
Fluor 488) (ab150077), anti-CD68 antibody (ab125212), and goat anti-rabbit IgG H&L 
(Alexa Fluor 647) were purchased from Abcam (Cambridge, MA). 4,6-Diamidino-2-
phenylindole (DAPI) was obtained from Invitrogen (Grand Island, NY). 
4.3.2 Synthesis, Preparation, and Characterization of PEG-DA Adhesives and 
their composites 
The synthesis of PEG-DA adhesive was synthesized with 4, 6, and 8-armed PEG 
(MW=10, 15, and 20 kDa, respectively, JenKem USA, TX) according to a previously 
published protocol 64. After purification, the adhesive was analyzed via NMR (Varion 
400 MHz) to determine the catechol coupling efficiency via H1-NMR with D2O.   
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The preparation of PEG-DA adhesive was done according to a previously published 
protocol 136. Briefly, PEG-DA (100, 225, or 300 mg) was dissolved in 1 ml of PBS 
solution (1x, 2x, or 4x) to create a PEG-DA precursor solution. The addition of acid-
treated silica particle (AHSi) (0, 5, or 10%wt) was done in the precursor solution to 
create a composite precursor solution. The particle was synthesized previously with the 
published protocol136. 11.6 mg of NaIO4 was dissolved in 1 ml of deionized water to 
create NaIO4 solution. The precursor solution and NaIO4 solution were mixed at a 1:1 v/v 
ratio to create PEG-DA adhesive and composites. The gelation time of the adhesive and 
the composite was determined with vial tilting technique as the adhesive gel rapidly. The 
adhesive was considered gelled when the solution ceased to flow in a scintillated vial. 
Lap shear adhesion test was performed using bovine pericardium while following a 
previously published protocol according to ASTM standard F2255-05 64. Strips of 
pericardium tissues (2.5 cm x 2.5 cm) were kept moist in PBS. 100 μl of PEG-DA 
precursor solution and NaIO4 solution with and without Si particles were mixed in a 
scintillated glass vial before being transferred on to the surface of the tissue. Another 
piece of pericardium tissue was applied over the adhesive to create an adhesive joint 
(overlapping area of 2.5 cm2), which was compressed with a 100-g weight for 15 min. 
The adhesive joint was submerged in PBS (pH = 7.4) at 37 °C overnight prior to testing. 
A digital caliper was used to measure the dimensions of the overlapped area of each 
adhesive joint before testing. The fixation of the tissue pieces on to the test stage was 
done with serrated metal grips to ensure sufficient traction. An Electroforce® machine 
(Bose Electroforce Group, MN) was used to pull apart the adhesive joint to failure at a 
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rate of 0.1 mm s−1. The adhesive strength was determined by the maximum load divided 
by the initial overlapped area of the adhesive joint.  
4.3.3 Systemic Study of H2O2 Release in PEG Adhesive Composites 
The robust design was utilized to predict the H2O2 concentration. The prediction was 
made utilizing the measured data from multiple experiments. Each factor that affects the 
material behavior was listed and ranked according to how large the effect of their change 
can be. PEG architecture, PEG precursor concentration, PBS concentration, and amount 
of incorporated AHSi were identified as largely affect the properties of the adhesive. The 
three properties that would significantly affect the material performance were determined 
(including gelation time, H2O2 concentration, and adhesive strength) as they are the most 
commonly reported value 136. Each factor was calculated through the mean value 
retrieved from real experiments. The mean observation value of the experiment was used 
to calculate the signal to noise ratio. Mean signal to noise ratio was then used to assign 
the weight to the factor effects. The equation used to find the signal to noise ratio for each 
formulation is as follow: 
S/N = -10×LOG(MSO)    (4) 
Where S/N is signal to noise ratio and MSO is mean squared observation. MSO can be 
calculated by 
MSO = ((1÷X1
2)+(1÷X2
2)+… +(1÷Xn
2))/n   (5) 
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Where X is the experimental data of each repeat, subscript denotes the repeat counts, and 
n is equal to the total number of repeats.  
The factor effect can then be complied from compiling signal to noise ratio into a 3*4 
matrix assigning the signal to noise prediction to each factor to each set of change 137, 138. 
Nine sets of experiments were conducted to collect the data needed for the predictions 
(Table 4).  
Table 4. Formulation required to fulfill the robust design matrix requirement 
Experiment 
Factors 
PEG 
Architecture 
PEG conc. 
(mg/ml) 
PBS conc. 
(x0.01M) 
%wt AHSi 
1 4 150 1 0 
2 4 225 2 5 
3 4 300 4 10 
4 6 150 2 10 
5 6 225 4 0 
6 6 300 1 5 
7 8 150 4 5 
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8 8 225 1 10 
9 8 300 2 0 
4.3.4 Systemic Study of PEG Composites in Dermal Wound Model in Mice  
The adhesive formation was selected to minimize the number of mice required to obtain 
meaningful data from the animal experiment. The first study criterion is the effect of the 
particle incorporation, which is a continued investigation from the in vitro result 
previously published form our group 136. The formulations were chosen to demonstrate 
the effect of the particle on the predicted reduction in H2O2 concentration and the 
increase in soluble silica concentration released from the composite. The second study 
criterion is the effect of the PEG-DA structure and their native H2O2 byproduct. The 
formulations were chosen to demonstrate the effect of the architectural alteration as well 
as the change in H2O2 concentration and release profile (Table 5). The number of mice 
required for bilateral experiment with three extra mice as backup is equal to 17 (Table 6)   
Table 5.  Formulation to be tested with the full thickness dermal wound in mice 
Formulation Silica Composite Group 
Control None A 
PEG-D6 None B 
PEG-D4 10%wt AHSi C 
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PEG-D6 10%wt AHSi D 
PEG-D8 10wt% AHSi E 
 
Table 6. Full list of treatments for all mice in the full thickness dermal wound repair 
experiment   
Mice# L R Time (Day) 
1 A B 14 
2 B C 14 
3 C D 14 
4 D E 14 
5 E A 14 
6 B A 14 
7 C E 14 
8 D C 14 
9 B E 7 
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10 A E 7 
11 A D 7 
12 E D 7 
13 C A 7 
14 D B 7 
15 E C 7 
16 B D 7 
17 C B 7 
 
4.3.5 Full Thickness Dermal Wound Repair model 
Female wild type mice (age 9-10 weeks, weight 20 g) were used to study the full-
thickness dermal wound model. All mice were subjected to a full-thickness wound model 
protocol modified from previously published protocols (Figure 21) 139-141. Mice were 
anesthetized with isoflurane before the hair was removed with electric shear and hair 
removal cream. One day after hair removal, the mice were anesthetized, and a 5 mm  
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Figure 21. Illustration (A) and photograph (B-I) of the step-by-step process of full-
thickness wound repair model in mice.  
tissue punch was used to create the wound on the back of the mice bilaterally to ensure 
identical wound size. Medical-grade silicon ring (outer diameter 10 mm, inner diameter 6 
mm) was fixated to the wound as a splint to prevent skin movement and change in wound 
size due to skin relaxation and shrinkage. The ring was first fixed with cyanoacrylate glue 
2 
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then 5-0 nylon suture was used to fix the ring with the skin. Four suture spots were used 
to ensure tight fixation as the fixing ring must survive until day 7 or 14. The wound was 
left open or was treated with PEG-DA adhesive and their composites. Images of the 
wound were taken for wound size analysis. The adhesive was allowed to gel for 2 
minutes before the wounds are covered with a non-stick wound dressing mesh (Adaptic). 
Sticky and breathable adhesive film (Hydrofilm) was used to attach the non-stick mesh 
on to the skin surrounding the wound. A large adhesive film piece was then used to 
completely seal off the wound from the surrounding element. The pain killer was given to 
the mice at 20 µl/day for three days after the surgery to ensure animal comfort. Wound 
dressing was inspected and replaced every day for the first four days after surgery. 
Images were taken at the same time as the wound redressing. Depending on the time 
group the mice were in, they were euthanized on day 7 or 14.      
4.3.6 Immunological and Histological Analysis of Dermal Wound Model 
After 7 or 14 days, the animals were euthanized via CO2 asphyxiation. The images of the 
extracted tissue samples were taken for wound size analysis via an Olympus microscope. 
The tissue samples were fixed in Polyfreeze and flash-frozen in a liquid nitrogen bath. 
The tissue was kept in -80oC for up to 4 weeks before sectioning with a cryomicrotome. 
The tissue slices were processed at the thickness of 10 µm mounted onto Histobond slide. 
There were 3 tissue section on each slides, at least 10 mounted tissue slides were 
produced for each tissue sample.   
77 
The immunological analysis of the dermal wound was done via CD68-DAPI fluorescence 
staining for macrophage population. The macrophage staining was done according to 
previously published protocol with minor modification 64. Samples were obtained from 
the -80°C freezer and fixed in 100% ethanol for 2 minutes. Samples were then washed 3 
times in PBS with Tween 20 (PBST) - 5 minutes each wash. Circles were then drawn 
around each sample using a hydrophobic marker. Endogenous blocking was completed 
using 10% Goat Serum diluted using 1% Bovine Serum Albumin (BSA) for 60 minutes. 
Samples were washed again in PBST 3 times - 5 minutes per wash. Next, samples were 
incubated in a 1/100 dilution Primary Anti-CD68 Ab (ab125212 – Rabbit Polyclonal) for 
12-14 hours at 4°C in a humidified chamber. Samples were washed again in PBST 3 
times - 5 minutes per wash and the lights remained off for the remainder of the stain. The 
samples were then incubated in a 1/200 dilution of the Secondary Antibody (Goat Anti-
Rabbit IgG H&L – AlexaFlour488) for 60 minutes at room temperature. Samples were 
washed again in PBST 3 times - 5 minutes per wash before being incubated in a DAPI 
antibody (1/1000 dilution) for 3 minutes and then the wash was repeated. Samples were 
mounted using an aqueous mounting medium and were imaged with 2-3 hours of the 
stain being completed. CD163 (M2-polarized macrophage stain) was not used. Image of 
the sample was taken immediately after the staining.   
The histological analysis of the dermal wound tissue was done via trichrome staining for 
wound morphology, epidermis analysis, and collagen content analysis. The trichrome 
staining was done according to previously published protocol 64. Samples were mounted 
using a permanent mounting medium. Additionally, keratin 6 staining was utilized to 
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analyze the wound maturity through the population of keratinocyte. The keratin 6 
staining was done according to previously published protocol with minor modification 
142. Instead of counterstaining with toluidine blue to stain the nuclei, Gill’s 3 hematoxylin 
solution (Sigma Aldrich) has been used in place of toluidine blue. Briefly, samples were 
rinsed in tap water and then immersed into the hematoxylin solution for 1-5 minutes. 
Samples were then rinsed in running tap water until thewater was colorless. The samples 
were then dipped 10 times in an acid rinse solution (2mL glacial acetic acid + 98mL diH 
2 O) followed by 10 dips in cool tap water. Then slides were dipped 5 times in a bluing 
solution (0.3mL NH 4 OH +100mL tap water) followed by 20 dips in tap water. Samples 
were then mounted using a permanent mounting medium and were stored overnight at 
4°C before imaging.  
Trichrome and keratin 6 stained tissue samples were imaged via EVOS microscope under 
polarized light. The overlaid images were processed via the Adobe Photoshop program 
auto stitching module. All image was measured and analyzed via ImageJ with wound 
healing tool macro with modifications 143.          
4.3.7 Statistical Analysis 
Statistical analysis was performed using JMP Pro 13 application (SAS Institute, NC). 
One-way analysis of variance (ANOVA) with Tukey-Kramer HSD analysis was 
performed for comparing means. p< 0.05 was considered significant.     
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4.4 Results and discussion 
4.4.1 A systemic study of H2O2 release in PEG adhesive composites 
The PEG-D4, PEG-D6, and PEG-D8 adhesive were synthesized (Figure 22). NMR 
spectra of each PEG adhesive have been analyzed (Appendix A). The coupling efficiency 
of each PEG adhesive was found to be over 90%. Ensuring their performance as 
adhesives with catechol functionalization. The formulation tested can be seen in Table 7. 
The difference between the predicted value and the experimental data are apparent on the 
effect of incorporating silica particle into the adhesive (Figure 23A and C). Adding silica 
particle was proven to reduce gelation time and increase adhesive strength 86, 136. 
However, the prediction model does not agree with this understanding. On the other 
hand, prediction on H2O2 concentration is effective enough to be able to predict the 
concentration of H2O2 at a 10-20% increase from the tested value (Figure 23B). 
Interestingly, the addition of AHSi provided a reduction in H2O2 by 20.24±0.67 µM 
regardless of PEG architecture, PEG concentration, and PBS concentration. The clearly 
limited reduction indicated that the effect of the particle on H2O2 reduction is governed 
by the available binding site on the particle 45, 136. As a result, the prediction model is not 
perfectly predicted the H2O2 concentration and completely ineffective in predicting 
gelation time. However, the prediction on the trend of H2O2 can be utilized to narrow 
down the formulation to be tested via maximum H2O2 concentration. The predicted 
formulation that fits the criteria for dermal wound repair can be seen in Table 8. All 
prediction data can be seen in Appendix A. 
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Figure 22. Chemical Structure of PEG-D4, PEG-D6, and PEG-D8. Single carbon (A), 
dipentaerythritol (B), and hexaglycerol (C) were used as the center group. 
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Table 7. Experimental result of the formulations required to fulfill the robust design 
matrix requirement 
Experiment 
Gelation Time 
(second) 
H2O2 (µM) 
Adhesive Strength 
(kPa) 
1 273.33±8.98 92.35±2.01 - 
2 45.83±3.44 89.30±1.72 3.17±0.18 
3 167.50±4.79 68.31±2.14 3.62±0.29 
4 515.00±13.84 52.36±1.91 - 
5 39.17±1.68 78.17±2.08 3.10±0.20 
6 52.83±2.27 72.22±2.15 5.31±0.16 
7 358.33±7.45 26.85±2.59 - 
8 85.50±4.23 32.33±1.49 4.26±0.29 
9 37.50±4.79 61.35±3.01 7.07±0.63 
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Table 8.  Predicted formulation that fit the criteria for dermal wound repair 
PEG 
Architecture 
Concentration 
(mg/ml) 
PBS 
conc. 
%wt 
AHsi 
Gelation 
Time 
H2O2 
conc. 
Adhesive 
Strength 
6 300 2 0 35.94 108.84 5.74 
6 300 2 10 95.57 69.54 5.11 
8 300 2 10 97.24 39.04 6.23 
4 300 2 10 119.58 86.27 4.52 
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Figure 23. Prediction vs. Experimental result of gelation time (A), maximum H2O2 
concentration (B), and adhesion strength (C). *p<0.05 when compared to their pair 
* 
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4.4.2 Dermal Wound Model in mice 
4.4.2.1 Wound closure  
Wound size measurement on the mice was done in a time-dependent manner. There was 
no difference in the wound size immediately after the surgery (Figure 24 and 25). 
However, after 7 days, the size of all the adhesive treated wounds is significantly smaller 
than the control wound. This is potentially due to the introduction of a physical coverage  
  
Figure 24. Representative image of the harvested tissue at day 0 (top), 7 (middle), and 14 
(bottom) of control (A,F,K), PEG-D6 (B,G,L), PEG-D6-AHSi(C,H,M), PEG-D4-AHSi 
(D,I,N), and PEG-D8-AHSi (E,J,O). Red and yellow dash line indicates the wound area.  
Scale bars are 1 cm.  
       Control  PEG-D6 PEG-D6-AHSi       PEG-D4AHSi        PEG-D8-AHSi 
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over the wound as well as the release of H2O2 in the first few days can help recruit 
immune cells as well as act as a chemotaxis source for keratinocyte recruitment. PEG-
D8-AHSi was found to have the smallest wound size among all the adhesive treated 
wounds. This may be due to the fact that the composite releases the least amount of H2O2, 
which might contribute to the shrinkage of the wound. Additionally, the wound treated 
with adhesives are seemingly completely closed. 
On day 14, control wounds have the scar tissue three times larger than all of the adhesive 
treated wounds. All catechol-AHSi composite treated wounds were found to have 
reduced wound size when compared to control suggesting that incorporation of soluble 
silica can induced faster wound closure when compare to the open wound. Interestingly,  
 
Figure 25. The wound area of the control wound and wound treated with different 
formulations of the adhesive. *p<0.05 when compared to their pair 
* * 
* 
* * 
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only PEG-D6 AHSi and PEG-D4 AHSi showed significant differences when compare to 
PEG-D6. We speculated that the H2O2 concentration level (50-80µM) and, presumably, 
increases in matrix stiffness contributed to such change when combined with the release 
of soluble silica 40, 64.   
4.4.3 Immunological Analysis of Dermal Wound Model 
To evaluate the effect of the particles on the biological response of the composite 
adhesives, catechol-based adhesive and their 10%wt AHSi composite with either 4,6, or 8 
arms architecture were introduced in on to the dermal wound repair model for 7 and 14 
days. 1*1 mm box was used to randomly selected the analysis area where the CD68 
positive cells, labeled in both green and blue, was count against the total population of 
cells, labeled in blue. A total of 3 counts was done for each image within the wound 
proximity then the counts were calculated for the approximation of CD68 population 
ratio. The ratio of CD68 to total cell number was found to be the highest in the first 7 
days then reduced to the lowest level in the control wounds (Figure 26 and 28). 
Interesting, both PEG-D6 and PEG-D6-AHSi demonstrated a significant reduction of 
CD68 population when compare to control on day 7 indicating lowered immunological 
response. Inversely, at day 14, the ratio of CD68 population of all adhesive and 
composite treated samples were found to be significantly higher than the control 
indicating increased immunological response (Figure 27 and 28). This increase in CD68 
population on day 14 suggested a prolonged immunological response. However, the 
macrophages involving in wound healing were thought to be roughly divided into two 
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types, M1 – inflammatory response and M2 – matrix remodeling. M2 macrophages are 
responsible for suppressing inflammatory responses, matrix remodeling, and tissue 
regeneration 64.The CD68 staining indicates only the population of macrophage without 
distinguishing the types of the cells. We speculated, with support from trichrome and 
keratin-6 results (Figure 31 and 34, respectively), that the wound remodeling 
macrophage is the dominant macrophage types in these wounds. The ratio of CD68 
population was not significantly different between PEG-D6 and PEG-D6-AHSi 
indicating that the inflammatory response of the two treatment groups are similar. 
However, the differences between PEG-D4 and PEG-D8 to PEG-D6 and PEG-D6-AHSi 
were observed. These results indicating that the wound react to the release of soluble 
silica and narrow shifts in H2O2 as PEG-D4 has higher H2O2 than PEG-D6 while PEG-D8 
has lower H2O2 concentration than PEG-D6. We theorized that the combination of 
soluble silica (≥10 µM) and H2O2 level at around 60 µM might be the ideal concentration 
to accelerate wound healing without causing significant increase in immunological 
responses similar to previous findings 64, 115.       
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Figure 26. Representative CD68-DAPI immunological image of the harvested tissue on 
day 7 after treatment with control (A), PEG-D6 (B), PEG-D6-AHSi(C), PEG-D4-AHSi 
(D), and PEG-D8-AHSi (E). Yellow dash line box giving the example for the area used 
to calculate CD68 positive cells. White dash line indicates the wound proximities. Green 
= CD68 positive cells and blue = cell nucleus. Scale bars are 1 mm.  
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Figure 27. Representative CD68-DAPI immunological image of the harvested tissue on 
day 14 after treatment with control (A), PEG-D6 (B), PEG-D6-AHSi(C), PEG-D4-AHSi 
(D), and PEG-D8-AHSi (E). Yellow dash line box giving the example for the area used 
to calculate CD68 positive cells. White dash line indicates the wound proximities. Green 
= CD68 positive cells and blue = cell nucleus. Scale bars are 1 mm.  
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Figure 28. The ratio of CD68 positive cells of the wound treated with different 
formulation of the adhesive. *p<0.05 when compared to their pair 
4.4.4 Histological Analysis of Dermal Wound Model 
Healthy skin tissue is comprised of the epidermis, dermis, panniculus muscle, and 
subcutaneous adipose tissue (Figure 29). When skin experience trauma, clotting cascade 
will be initiated to stop the bleeding, then an inflammatory response will start by 
recruiting neutrophil, macrophage, and fibroblast. The granulation tissue (gr), which is a 
vascularized, not-well-defined tissue, and connective tissue will start from. The amount 
of granulation tissue and connective tissue is governed by the healing process of the 
wound. With higher inflammatory response and heal poorly, higher connective tissue and 
collagen synthesis are to be expected. At a later stage of a healing wound, tissue 
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remodeling occurred, and the tissue structure will start to resemble a healthy skin 
structure. On the other hand, poorly healed scars will end up with an excess amount of 
collagen as well as poor tissue remodeling, causing the newly formed skin to look 
distinctly different than that of healthy skin.  
Histological staining images were collected and analyzed with 2 tissue slides from 3 
repeat of each sample group (n=6 for each group). Masson’s trichrome staining is 
generally utilized to study the skin tissue for their morphology and structural content of  
 
 
Figure 29. Histological analysis of skin structure and thickness. Scheme of skin structure 
(A), histological skin sections stained with Masson trichrome and collected from young 
(8-12 week-old) and old (16-20 week-old) mice fed with normal diet for a period of 8 
weeks (B), quantification of the skin layers thickness: the epidermis (C) Epi - epidermis, 
dWAT - dermal white adipose tissue, F-rd fibroblast rich dermis; scale bar 200 μm. 
Adapted from reference 144 under the terms of the Creative Commons Attribution License 
(CC BY 3.0) 
A                B   C 
92 
the sample. Trichrome staining on skin tissue stains collagen in blue, muscles, and other 
connective tissues in red, and cell nucleus in dark brown (Figure 29). 
The wound proximities were found to be in irregular shapes, which are the result of 
dermal contractions 145. The results from tissue sample harvested on day 7 after surgery 
indicate a faster wound healing in the adhesive treated samples with thicker epidermis 
formation when compared to control (Figure 30 and 32A). This increased epidermis 
thickening or dermal hyperplasia is thought to be the effect of H2O2 treatment, as 
reported by others in the field 146, 147. The thickest epidermis layer was observed in PEG-
D4-AHSi, which has the highest H2O2 concentration among the composite samples 
following by PEG-D6-AHSi and PEG-D8-AHSi, which has the lowest H2O2 
concentration (Figure 23B). PEG-D6 treated sample also demonstrated an increase in 
epidermal thickness, but the increase is not significantly different than those observed in 
PEG-D6 AHSi and PEG-D4-AHSi. The result suggested that the increase in epidermal 
thickness is not only affected by hydrogen peroxide concentration but also the release of 
soluble silica.  
The collagen content determined through the measurement of collagen layer thickness. 
The thickness of the collagen layer in the control sample tissue is significantly thicker 
than those of the adhesive treated samples (Figure 30 and 32B). The granulation tissue 
formation was found to be the most prominent in PEG-D4-AHSi, which has the highest 
amount of H2O2 (>80 µM) followed by PEG-D6-AHSi (between 40 and 80 µM), and 
PEG-D8-AHSi (<40 µM). Interestingly, PEG-D6 (approximately 100 µM of H2O2) 
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treated wound demonstrate dermal layer structure, which resembles those of healthy 
tissue the most. This may be due to the fact that a high concentration of H2O2 (as low as 
1000 µM for one-time dose) can leads to epidermolysis and rapid new epidermal 
formation with epidermal hyperplasia as evident in the epidermis analysis 93, 147.   
However, this result is not consistent across all the mice, which strongly suggested by the 
large standard deviation. This is to be expected as the lack of control over the release of 
H2O2 release as well as weaker material integrity, resulting in a large variety of biological 
responses.  
Trichrome staining results of tissue samples harvested on day 14 after surgery indicate 
healthy wound remodeling on all adhesive treated samples (Figure 31). Smaller wound 
proximity, as well as increased granulation tissue and reduction in collagen layer 
thickness, have been observed in all adhesive treated formulation. PEG-D6 and PEG-D6-
AHSi demonstrated tissue remodeling, which is resembling healthy tissue. A similar 
tissue remodeling trend was also observed in PEG-D4-AHSi, and PEG-D8-AHSi treated 
samples. However, the collagen thickness is higher in these groups when compared to the 
PEG-D6 and its composite. This might be attributed to the fact that the healing process of 
PEG-D6 involved early thermolysis and new epidermal formation since the hydrogen 
peroxide concentration of the adhesive is closer to 100 µM at their maximum 
concentration. For PEG-D6-AHSi, it is possible that the amount of sustained release of 
H2O2 resulted in a similar biological response at day 14 as the lagged healing process was 
observed in day 7 sample groups. PEG-D6—AHSi demonstrated the thinnest collagen 
layer (Figure 32) which might suggest that the wound remodel successfully at day 14.  
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 Figure 30. Representative trichrome histological image of the harvested tissue on day 7 
after treatment with control (A), PEG-D6 (B), PEG-D6-AHSi(C), PEG-D4-AHSi (D), 
and PEG-D8-AHSi (E). Black (A-B) and Yellow (C-E) dash line indicate the area used to 
calculate collagen content. White dash line indicates the wound proximities. es = eschar, 
gr = granulation tissue, and ep = epidermis. Scale bars are 1 mm.  
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Figure 31. Representative trichrome histological image of the harvested tissue on day 14 
after treatment with control (A), PEG-D6 (B), PEG-D6-AHSi(C), PEG-D4-AHSi (D), 
and PEG-D8-AHSi (E). Black (A and C) and Yellow (B, D, and E) dash line indicate the 
area used to calculate collagen content. White dash line indicates the wound proximities. 
es = eschar, gr = granulation tissue, and ep = epidermis. Scale bars are 1 mm.  
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Figure 32. The epidermis thickness (A) and collagen layer thickness (B) of the wound 
treated with different formulation of the adhesive. *p<0.05 when compared to their pair 
Interestingly, all-composite adhesive treated samples demonstrated a significantly thinner 
epidermal when compare to PEG-D6 (approximately 25 µm vs. 140 µm), suggesting the 
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lack of epidermal hyperplasia. In fact, the thickness of the epidermal in these treatment 
groups matched with the thickness of epidermal in the healthy tissue in the wild-type and 
age-matched mice (Figure 29C.)144. Interestingly, the keratinocyte population observed 
in both PEG-D6-AHSi and PEG-D8-AHSi (H2O2 concentration <80 µM) are significantly 
higher than those observed in both PEG-D6 and PEG-D8-AHSi (H2O2 >80 µM). The 
result suggested that AHSi addition combining with appropriate adhesive architecture or 
H2O2 concentration, i.e., PEG-D6-AHSi, can lead to wound remodeling, which resembles 
healthy tissue without epidermal hyperplasia.  
Keratin-6 suggested that adhesive treatment increase keratinocyte recruitment. In 
addition, adding particle in the adhesive further increases keratinocyte recruitment on day 
7 after surgery (Figure 33 and 35). Keratinocyte content is a sign of skin maturation as 
keratinocyte maturation completes the cornification of the skin, providing the outermost 
layer of protection to the dermal tissue below 148. The increase in keratin 6 positive cell 
population in the epidermis and surrounding tissue (approximately 82% with higher than 
90% in the epidermis) in adhesive treated samples suggested that the skin can undergo 
maturation earlier than the control sample for at least a week. The population of 
keratinocyte was found to be concentrated in the epidermis and the surrounding tissue, 
which conforms with normal skin tissue structure149, 150. H2O2 was found to increase 
keratinocyte proliferation as a response to oxidative stress38, 151. Moreover, soluble silica 
is also reported to increase keratinocyte proliferation as well as induce fibroblast and 
keratinocyte migration 76, 136. Additionally, incorporation of silica particle increases the 
stiffness of the adhesive, which contribute to fibroblast and keratinocyte proliferation 
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Figure 33. Representative keratin-6 histological staining images of the harvested tissue at 
day 7 of control (A), PEG-D6 (B), PEG-D6-AHSi(C), PEG-D4-AHSi (D), and PEG-D8-
AHSi (E). Red dash line indicates the area used to calculate keratinocyte content. White 
dash line indicates the wound proximities. Scale bars are 1 cm.  
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Figure 34. Representative keratin-6 histological staining images of the harvested tissue at 
day 14 of control (A), PEG-D6 (B), PEG-D6-AHSi(C), PEG-D4-AHSi (D), and PEG-
D8-AHSi (E). Red and yellow dash line indicates the area used to calculate keratinocyte 
content. White dash line indicates the wound proximities.  Scale bars are 1 cm. 
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Figure 35. The ratio of keratin-6 positive cells of the wound treated with different 
formulation of the adhesive. *p<0.05 when compared to control in the same time group 
when direct cell-material contact was established 136, 152. The control sample 
demonstrated the least amount of keratin-6 positive cells suggesting the lagged 
maturation progress. 
Keratin 6 stainings on tissue samples harvested on day 14 after surgery showed an 
increase in keratinocyte population in control samples, while a general reduction in the 
population was observed in all samples with adhesive treatment. The keratinocyte 
population in all adhesive treatments were not significantly different and was found to be 
around 40% of the total cell population (approximately 40% with 90% in the epidermis). 
This reinforces the assumption that the introduction of adhesive treatment was 
contributing to the early maturation of keratinocyte and keratinocyte recruitment.  
The population of keratinocyte reduced 14 days after surgery samples (Figure 34 and 
35). This is presumably due to the early maturation of the keratinocyte allowing the 
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dermal tissue remodeling as keratinocyte are key cells that regulate dermal fibroblast 
activity and dermal wound healing 149. This observation correlated with the trichrome 
staining result, which suggested the near-complete tissue remodeling in PEG-D6-AHSi 
treated sample (Figure 31C.).   
The combination of trichrome and keratin 6 (Figures 32 and 35) strongly suggested the 
H2O2 concentration-dependent response of dermal wound healing 
147, 153. The 
concentration of H2O2 that presumably accelerate wound healing was reported to be 
varying from 10-103 µM. However, with the full thickness wound model result, we 
narrow down the concentration that specific to the dermal wound to be between 
approximately 40-100 µM. However, H2O2 alone does not contribute to fully remodeled 
tissue at 14 days after the injury, as suggested by epidermal hyperplasia observed in the 
PEG-DA adhesive treated samples (Figure 31 and 32A). The incorporation of AHSi, 
which can release soluble silica in a biologically relevant concentration, also contributes 
strongly to the epidermal formation and tissue remodeling 136, 148, 149. The particle 
participates in reducing the H2O2 concentration while altering the material stiffness, 
which positively affects the wound healing process in vivo136. The wound was remodeled 
to mostly resemble healthy tissue on day 14 after the injury, as demonstrated by 
trichrome staining. The lack of epidermal hyperplasia suggested no excessive thermolysis 
and inflammatory response took place during the healing process. AHSi or soluble silica 
was demonstrated to play a critical role in inducing keratinocyte and fibroblast 
proliferation and migration, which directly affect dermal wound healing in vitro 76, 136. 
For the observed in vivo results, the author proposes the simplified relationship between 
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H2O2, material property, and AHSi (Scheme 4) to help better understand the interaction 
observed in this manuscript.  However, the full understanding of the AHSi or soluble 
silica, and their biological effect is not fully understood and should be considered to be a 
fruitful endeavor for future study. 
 
Scheme 4. H2O2, material property, and AHSi on dermal wound healing 
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4.5 Conclusions 
10%wt silica nanoparticle-containing adhesive hydrogels were formulated to tune the 
H2O2 concentration released from the PEG-DA adhesive with various architecture. The 
robust design of the experiment was utilized to narrow down the candidate formulation 
and expected H2O2 concentration for dermal tissue repair application. FOX assays 
confirmed the amount of H2O2 can be estimated through robust design with a 10-20% 
deviation. Incorporation of silica particle effectively reduces the H2O2 concentration 
released from the adhesive regardless of their architecture. Lap shear tests confirmed the 
adhesive improve their adhesive strength with the addition of silica particles. The 
adhesive was successfully introduced in a full-thickness wound repair mice model. The 
result suggested that the adding catechol adhesive helped accelerate wound closure but 
fail to achieve a fully remodeled to healthy dermal tissue due to epidermal hyperplasia. 
The addition of AHSi proves to be beneficial for the adhesive in maintaining the ability 
to accelerate wound healing while reducing the epidermal hyperplasia. Ultimately, with a 
combination of appropriate adhesive architecture, H2O2 concentration, and addition of 
AHSi, an accelerated wound healing with better tissue remodeling was achieved. This 
proof of concept study strongly suggests the design of adhesive that considered the 
aforementioned factors to achieved tissue-specific response. However, a full 
understanding of the target tissue and their healing process is required to utilize this 
strategy effectively.    
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5 Summary and Future Outlook 
5.1 Summary 
In Chapter 1, we established an understanding of ideal bioadhesive design and catechol 
based adhesive. The byproduct of catechol-based adhesive and the effect of H2O2 on 
biological response was discussed at length. We thus proposed the alternative approach to 
control the release of H2O2 from catechol adhesive with a biologically active silica 
particle incorporation.  
Chapter 2 revolves around the detailed investigation of silica particle synthesis and the 
exploratory investigation on altering surface chemistry on the silica particle. In the later 
part of the chapter, we have describes the factor that directly affects silica particle 
synthesis, especially with Stӧber synthesis approach. Several surface modification 
techniques have also been investigated with the resulting silica particle. This was further 
corroborated by various tests on the particle surface interaction with H2O2 in chapter 3 
with various methods at physiological conditions.     
Although the particle demonstrated promising characteristics and interaction with H2O2, 
the application of such a particle is still unproven. In chapter 3, we investigate the effect 
of the particles on H2O2 generation and the effect of incorporating the particle on various 
types of cells and in the wound healing model in mice. We demonstrated that the particle 
still remains effective even after incorporation into PEG-DA adhesives in reducing H2O2 
concentration. The particle also positively affects the biological response of RDF, HT, 
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and HEK, increasing cell proliferation and reduce toxicity in some formulation. The 
results were indicating that targeted-application and targeted-tissue adhesive design from 
such a concept can be achieved.  
The ability of the silica particle and composite adhesives (reported in Chapters 2-3) to 
modulate the different concentrations of H2O2 was thought to be largely limited by the 
availability of surface binding sites as well as slow degradation of H2O2. To address this 
concern, in Chapter 4, we study a wider range of adhesive formulations to find the extent 
of H2O2 modulation that the particle can provide. We demonstrated that, with careful 
selection of material and their control factors, a representative formulation from silica 
particle-PEG-DA composite could achieve the desired biological response in vivo via a 
full-thickness wound repair model in mice. The results strongly suggested that, with 
appropriate selection and control of H2O2 release level, dermal wound healing time can 
be reduced by at least 50% with a complete tissue remodeling.  
5.2 Future Outlook 
This dissertation describes the progress made toward controlling the H2O2 concentration 
during the oxidation of catechol adhesive through oxidative mediated oxidation by the 
introduction of surface activated silica particle for H2O2 sorption and complexation. The 
assays for multiple formulations of PEG-DA adhesives and particle composites were also 
included, which will facilitate the decision of formulation selection for future studies.   
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In Chapters 2-3, the particle was synthesized as a fully amorphous particle to allows 
better surface reactivity and ease of functionalization. Increasing the total surface area of 
the particle proves to be one of the effective modifications to increase the particle 
capability to react with H2O2. Alternatively, post-synthesis heat treatments or adjustments 
during synthesis (i.e., increased temperature, change of silica precursor, etc.) can be made 
to alter the degree of crystallinity. A stronger functionalization method can be still be 
used to alter surface chemistry, while increased crystallinity will likely increase the 
catalytic effect of the silica particle. Doping silica particles with metallic species might 
also result in a better catalytic degradation effect while maintaining the biocompatibility 
level of the composite as well. Since silica particle is easily modifiable, the possibility is 
nearly endless.  
In Chapter 4, Increasing or decreasing silica particle is also proved to drastically affect 
the biological response both in vivo and in vitro (as demonstrated in Chapter 3 and 4). 
However, the incorporation of the particle is seemingly more suitable for fine-tuning the 
H2O2 concentration range than utilizing solely to control the high amount of H2O2. PEG-
DA formulation proved to be one of the biggest deciding factors for the composite 
adhesive biological response as they are directly responsible for the H2O2 generation. 
Modifying the adhesive formulation and structure, then fine-tuning the adhesive bulk 
properties and H2O2 concentration level, could be a more effective approach to control 
the cytotoxicity and biological response. The author firmly believes that combing all the 
knowledge established in this dissertation would lead to a successful design of tissue-
specific adhesive formulations with the ability to accelerate tissue repair.   
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Appendix A. 
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NMR Spectra of PEG-D6 
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NMR Spectra of PEG-D8 
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Prediction result from the robust design functions. The grey highlighted rows are the 
selected formulation. 
Polymer 
type 
Polymer 
conc. 
PBS 
Conc. 
Particle 
wt% 
Gelation 
time 
Max 
H2O2 
Adhesive 
Strength 
4 150 1 0 272.89 92.29 1.00 
4 150 1 5 354.88 67.23 0.92 
4 150 1 10 725.72 58.96 0.89 
4 150 2 0 242.06 101.45 0.99 
4 150 2 5 314.78 73.91 0.91 
4 150 2 10 643.73 64.82 0.88 
4 150 4 0 338.63 80.21 0.79 
4 150 4 5 440.38 58.43 0.73 
4 150 4 10 900.56 51.25 0.70 
4 225 1 0 39.39 111.45 3.45 
4 225 1 5 51.22 81.19 3.17 
131 
4 225 1 10 104.75 71.21 3.07 
4 225 2 0 34.94 122.51 3.43 
4 225 2 5 45.44 89.25 3.15 
4 225 2 10 92.91 78.28 3.05 
4 225 4 0 48.88 96.86 2.73 
4 225 4 5 63.56 70.57 2.50 
4 225 4 10 129.98 61.89 2.43 
4 300 1 0 50.69 122.82 5.11 
4 300 1 5 65.92 89.48 4.69 
4 300 1 10 134.82 78.47 4.54 
4 300 2 0 44.97 135.02 5.08 
4 300 2 5 58.48 98.36 4.67 
4 300 2 10 119.58 86.27 4.52 
4 300 4 0 62.91 106.75 4.03 
4 300 4 5 81.81 77.77 3.71 
132 
4 300 4 10 167.29 68.21 3.59 
6 150 1 0 218.09 74.39 1.13 
6 150 1 5 283.61 54.20 1.04 
6 150 1 10 579.98 47.53 1.01 
6 150 2 0 193.45 81.78 1.12 
6 150 2 5 251.57 59.58 1.03 
6 150 2 10 514.45 52.25 1.00 
6 150 4 0 270.62 64.66 0.89 
6 150 4 5 351.94 47.10 0.82 
6 150 4 10 719.71 41.31 0.79 
6 225 1 0 31.48 89.84 3.90 
6 225 1 5 40.94 65.45 3.59 
6 225 1 10 83.71 57.40 3.47 
6 225 2 0 27.92 98.76 3.88 
6 225 2 5 36.31 71.95 3.56 
133 
6 225 2 10 74.25 63.10 3.45 
6 225 4 0 39.06 78.08 3.08 
6 225 4 5 50.80 56.88 2.83 
6 225 4 10 103.88 49.89 2.74 
6 300 1 0 40.51 99.01 5.77 
6 300 1 5 52.69 72.13 5.30 
6 300 1 10 107.74 63.26 5.14 
6 300 2 0 35.94 108.84 5.74 
6 300 2 5 46.73 79.29 5.27 
6 300 2 10 95.57 69.54 5.11 
6 300 4 0 50.27 86.05 4.55 
6 300 4 5 65.38 62.69 4.19 
6 300 4 10 133.70 54.98 4.05 
8 150 1 0 221.91 41.77 1.38 
8 150 1 5 288.58 30.43 1.27 
134 
8 150 1 10 590.14 26.69 1.23 
8 150 2 0 196.83 45.92 1.37 
8 150 2 5 255.97 33.45 1.26 
8 150 2 10 523.46 29.34 1.22 
8 150 4 0 275.37 36.30 1.09 
8 150 4 5 358.10 26.45 1.00 
8 150 4 10 732.31 23.20 0.97 
8 225 1 0 32.03 50.44 4.76 
8 225 1 5 41.65 36.75 4.37 
8 225 1 10 85.18 32.23 4.23 
8 225 2 0 28.41 55.45 4.73 
8 225 2 5 36.95 40.40 4.35 
8 225 2 10 75.56 35.43 4.21 
8 225 4 0 39.75 43.84 3.76 
8 225 4 5 51.69 31.94 3.45 
135 
8 225 4 10 105.70 28.01 3.34 
8 300 1 0 41.22 55.59 7.04 
8 300 1 5 53.61 40.50 6.47 
8 300 1 10 109.63 35.52 6.26 
8 300 2 0 36.57 61.11 6.99 
8 300 2 5 47.55 44.52 6.43 
8 300 2 10 97.24 39.04 6.23 
8 300 4 0 51.15 48.32 5.55 
8 300 4 5 66.52 35.20 5.11 
8 300 4 10 136.04 30.87 4.94 
 
